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Nanomaterials are well-suited for a variety of applications because of their unique properties 
on the nanoscale. Interest in using gold nanoparticles in biological applications is growing ranging 
from sensing to cancer therapy due to their tunable sizes and shapes, unique optoelectronic properties, 
and straightforward surface modification. The advancement of fine-tuning of gold nanoparticle sizes, 
shapes, and surface chemistry is critical for various applications. However, many of these applications 
are developed in controlled environments, and not subject to the complex biological systems. Indeed, 
the interaction between gold nanoparticles and biological systems cannot be predicted by a single 
physiochemical property of nanoparticles. This interaction comes from an ensemble, combining all 
nanoparticle physiochemical properties and the complexity of biological systems. As a result, a 
fundamental understanding of how nanoparticle physiochemical properties influence biological 
systems is a building block for the foundation of many applications.  
 
Chapter 1 will introduce the concept of nanomaterials and their unique properties. Then 
syntheses and surface modification of gold nanoparticles will be introduced. These include seed-
mediated growth of gold nanospheres and nanorods and the control over absolute dimensions of 
gold nanoparticles. Then the surface modification of gold nanoparticles, including thiol 
functionalization, and layer-by-layer polyelectrolyte and mesoporous silica coatings are addressed. 
Finally, challenges of applying nanoparticles in biological systems are discussed. 
 
Chapter 2 focuses on controlling absolute lengths and widths of gold nanorods toward 
tunable longitudinal localized surface plasmon resonance. Precise control over gold nanorod 
widths less than 10 nm accompanied by increasing gold nanorod lengths was achieved by a seed-
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mediated growth method. These seed-mediated growth of mini gold nanorods leads to excellent 
shape percent yields and > 79% of gold ion reduction. We show that liter-scale mini gold nanorod 
syntheses are reproducible and their dimensions and shape percent yields are comparable to those 
of a small-scale synthesis. 
 
We elucidate the size effect of gold nanorods on cellular uptake and removal in Chapter 3. 
To correlate how each parameter (width, length, aspect ratio, and dimension) influences endo- and 
exocytosis, four different seed-mediated growth methods were introduced to prepare four types of 
rods. We found that a low correlation exists between the cellular uptake of gold nanorods and rod 
lengths, but there is a negative correlation between the cellular uptake of rods and rod widths in 
primary human pulmonary artery endothelial cells.  We also investigated gold nanorod secretion 
kinetics in a 10 h interval. At the end of 10 h, > 75% of rods were removed from the cells.  
 
The impact of gold nanoparticle aerosols on human airway epithelium differentiation is 
discussed in Chapter 4. We show how to build a 3-dimentional human lung model cultured at an 
air-liquid interface. Gold nanosphere aerosols were delivered to the cocultures of primary human 
pulmonary cells through nebulization to mimic human inhalation. Our lung model shows 
successful epithelium differentiation regardless of gold nanosphere aerosol exposure. However, 
changes of inflammatory responses remained after aerosol exposure.  
 
In Chapter 5, we conclude the fine-tuning of gold nanorod lengths and widths, the size 
dependent endo- and exocytosis of gold nanorods in primary human pulmonary artery endothelial 
cells and the effect of gold nanosphere aerosols on human small airway epithelium differentiation. 
Finally, applications of mini gold nanorods with tunable plasmonic properties and possible 
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upcoming experiments to elucidate the effect of gold nanoparticle size and surface chemistry on 
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CHAPTER 1: AN INTRODUCTION TO GOLD NANOPARTICLES 
 
1.1 Introduction to Gold Nanoparticles 
Nanoparticles (NPs) are one-dimension materials with sizes ranging from 1 to 100 nm. At 
this nanometer (1 × 10-9 m) scale, NPs exhibit unique properties different from small molecules 
and bulk materials. These new optoelectronic and mechanical properties arise from their small 
sizes, high surface-to-volume ratios and electron confinement.1 Unlike bulk gold, nanoscale gold 
exhibits diverse colors (Figure 1.1).2 In additional to different optical properties, NPs and their 
counterpart bulk materials vary in mechanical properties. The bending of bulk copper occurs with 
the movement of copper atoms at about 50 nm. Copper NPs smaller than 50 nm, however, are 
super hard materials that do not exhibit the same malleability and ductility as bulk copper.3 
 
Gold nanoparticles (AuNPs) are one of the most highly used NPs due to their chemically 
stable core,4 tunable sizes and shapes,5-6 various surface modification6 and tailorable optical 
properties.7 Michael Faraday was the first to show the interesting optical property of colloidal gold 
back to 1857.7 He described his colloidal gold solution as “beautiful ruby fluid”. Years later, 
Gustav Mie showed that the interaction of NPs with light was determined by the particle size, 
complex frequency-dependent dielectric function of the material and the dielectric constant of the 
surrounding medium.8 This optical phenomenon is called a localized surface plasmon resonance 
(LSPR), resulting from the free electrons at the NP surface oscillating collectively in resonance 
with the electric field of the light (Figure 1.2). Unlike spherical NP with only one LSPR, 
anisotropic gold nanorods (AuNRs) exhibit two LSPR peaks (Figure 1.2). One corresponds to the 
width of the AuNR called transverse LSPR; the other is longitudinal LSPR, resulting from the 
electron oscillation along the length of the AuNR. The longitudinal LSPR is tunable from visible 
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to near-infrared spectra through NR aspect ratio, which is the ratio of the length to the width of the 
rod. The electron oscillation at the NP surface forms strong electromagnetic fields, which can be 
released radiatively and non-radiatively as scattering light or being converted into heat. The release 
of heat causing thermal ablation of a diseased area is called photothermal therapy. Both the 
scattering light and heat from the enhanced electromagnetic fields of the NPs are widely used in 
imaging,9 sensing,10 photothermal therapy,11 optical limiting,12 LEDs13 and solar cells.14   
 
 
Figure 1.1. a) A gold medal presented at the Games of the II Olympiad (Paris, France; 1900). b-
d) Vivid colors of colloidal solutions with b) gold nanorods, c) gold nanoparticles with silica shells, 
and d) gold nanocages. Images a-d) reprinted with permission from ref. 2. Copyright 2012 the 





Figure 1.2. a) Electron oscillation along the width and the length of AuNRs leading to the 
transverse and longitudinal localized surface plasmon resonances (LSPR). Gray arrows show the 
conduction band electron oscillation. b) Visible-near-infrared extinction spectra of AuNRs with 
different aspect ratios (ARs). TEM images of AuNRs with ARs c) 1.1, d) 2.0, e) 2.7, f) 3.7, and g) 
4.4. Scale bars are 50 nm. Images a-g) reprinted with permission from ref 6. Copyright 2016 
American Chemical Society. 
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1.2 Synthesis of Gold Nanoparticles 
John Turkevich was the first person who created a standard method for spherical AuNP 
synthesis.15 In a boiling solution of gold (III) chloride trihydrate (HAuCl4 • 3H2O), sodium citrate 
was used as a reducing agent to reduce the Au3+ ions into to metallic Au0. The size of gold 
nanospheres (AuNSs) synthesized by this method can be tuned by reducing the amount of sodium 
citrate added to the boiling solution or by increasing the boiling time. This synthesis can produce 
AuNSs ranging from ~10-40 nm. Sodium citrate also acts as a stabilizing agent, providing 
electrostatic repulsive forces to prevent gold metal cores from coalescing.  
 
Making larger AuNSs requires to separate the nucleation and the growth steps of AuNSs 
by preparing seed and growth solutions separately.  Rodríguez-Fernández et al. synthesized 
cetyltrimethylammonium bromide (CTAB)-capped AuNSs ranging from 12 to 180 nm through 
preparing 12-nm gold seeds first and then using ascorbic acid to reduce a growth solution mixed 
with HAuCl4 • 3H2O and CTAB.
16 This method, however, requires a post-synthetic purification to 
remove shape impurities. One of the most widely used AuNS preparation methods was developed 
by Perrault et al., which produces NPs of 50-200 nm through a weaker reductant hydroquinone.17 
Recently, monodispersed, ascorbic acid-reduced AuNSs with diameters of 15-300 nm were 
reported by Ziegler and Eychmuller.18 To achieve higher shape purity and monodisperse AuNSs, 
there were 3 growth steps involving a serial dilution of a previously prepared growth solution.  
 
Seed-mediated growth can also be used to produce AuNRs. The advantage of using seed-
mediated methods for synthesizing anisotropic NPs is better control over the growth kinetics of 
NP and its morphology.6 The most widely used procedures for AuNR syntheses were developed 
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by Nikoobakht and El-Sayed19 and us.20 AuNRs made by those methods range from 30 to 80 nm 
in length and 10 to 20 nm in width.21-27 A gold seed solution was prepared by reducing HAuCl4 • 
3H2O  with a stronger reductant sodium borohydride. In a growth solution containing HAuCl4 • 
3H2O and silver nitrate (AgNO3), ascorbic acid was added to reduce Au
3+ ions to Au1+.29-30AgNO3 
induces the anisotropic growth of AuNRs and the AR of NRs can be tuned by the amount of 
AgNO3 present in the growth solution.
28-29  
  
Fine tuning AuNR sizes and ARs can be achieved by adding organic additives,30 and 
changing halide counterions,31 surfactants,5 reducing agents,32 the amount of seeds and pH in the 
growth solution.31,34 For example, through using a weaker reducing agent hydroquinone 
Vigderman and Zubarev developed AuNRs with ARs larger than 6, longitudinal LSPR up to 1200 
nm and near 100% of gold ion reduction.32 Moreover, Murray and coworkers demonstrated that 
by mixing sodium oleate and CTAB together in the growth solution, the widths of AuNRs 
increased significantly to 70 nm.31 Our recent study and others’ show that the widths of AuNRs 
could be precisely controlled within less than 10 nm (Figure 1.3), but the longitudinal LSPR was 











Figure 1.3. a) Visible-near-infrared extinction spectra of AuNRs with tunable longitudinal LSPR, 
but NR widths precisely controlled < 10 nm.  TEM images of AuNRs with ARs b) 2.2 and c) 10.8 
corresponding to the red and navy-blue spectra in image a), respectively. Images adapted with 








1.3 Surface Modification of Gold Nanoparticles 
1.3.1 Thiol Functionalization  
To achieve desirable applications, the surface of AuNRs can be modified by alkanethiols, 
polyelectrolytes, and silica shells. Most of the as-synthesized AuNSs and NRs are capped by 
sodium citrate or CTAB. CTAB, however, has been demonstrated to be cytotoxic, limiting the use 
for biological applications.35 Ligand exchange is one of the widely used and the most 
straightforward ways to replace the sodium citrate and CTAB on the AuNP surface with other 
ligands. Alkanethiols are the most commonly used molecules for ligand exchange on AuNPs due 
to the relatively strong gold−thiolate bond (∼44 kcal/mol).36 However, the hydrophobicity of 
alkanethiols can be challenging for ligand exchanges. The aggregation of AuNPs could result from 
the direct replacement of CTAB by thiolated ligands. We have addressed these challenges by 
replacing CTAB-capped AuNRs by methoxy poly(ethylene glycol) thiol (mPEG-SH) of a 
molecular weight of 1−10 kDa, transferring the PEGylated AuNRs to a suitable solvent, and finally 
performing ligand exchange of the PEG-SH for the desired small molecule thiol (Figure 1.4).37 To 
replace the CTAB bilayer on AuNPs by PEG-SH, excess CTAB must be removed first and then 
PEG-SH is added to a AuNP aqueous solution and allowed to attach to the NP surface.38 To remove 
excess and free PEG-SH present in the aqueous solution, functionalized AuNPs are centrifuged 
and suspended in an organic solvent. The phase transfer of PEG-SH-functionalized NPs from 
aqueous to organic phases can be accomplished by centrifugation39 or without centrifugation. 
Through using a common solvent that is miscible in both aqueous and organic phases, 
centrifugation can be avoided entirely.39After AuNPs are in the organic phase, PEG-SH can be 




Figure 1.4. Schematic representation of the ligand exchange replacing CTAB with PEG-SH 
followed by the place exchange of PEG-SH for another alkanethiol. Image reprinted with 
permission from ref 6. Copyright 2016 American Chemical Society. 
  
1.3.2 Polyelectrolyte Coating 
Another straightforward approach to modify the AuNP surface is to deposit charged 
polyelectrolytes on the NP surface; i.e., positively and negatively charged polyelectrolytes are used 
for citrate-and CTAB-capped NPs, respectively. Multilayers of polyelectrolytes can be built on the 
NP surface by alternatively adding polyelectrolytes of opposite charges, i.e. a layer-by-layer (LBL) 
assembly of negatively charged poly(sodium-4-styrenesulfonate) (PSS) and positively charged 
poly(diallyldimethylammonium chloride) (PDADMAC) shown in Figure 1.5.40 Successful LBL 
assembly of polyelectrolytes on NPs depends upon a balance between the ionic strength and the 
polymer molecular weight. Employing large polymers to wrap NPs requires longer diffusion time, 






Figure 1.5. Schematic representation of the layer-by-layer (LBL) coating process of AuNRs. 
Common anionic and cationic polyelectrolytes used for LBL assembly are shown in blue and red, 
respectively. Image adapted with permission from ref 40. Copyright 2005 American Chemical 
Society. 
 
The advantage of the LBL coatings is that NP surface charges can be easily modified. Sisco 
et al. showed that the toxicity of AuNRs was significantly reduced after NRs were coated by 
poly(acrylic acid) (PAA) and poly(allylamine hydrochloride) (PAH) due to the covering up of the 
CTAB bilayers.36 The electrostatic interactions between the LBL assembly of polyelectrolytes also 
allows for loading molecules on or within the polyelectrolyte multilayers. Gandra et al. showed 
that by applying polyelectrolytes as dielectric spacers on immobilized AuNRs, they probed 
distance-dependent plasmon-enhanced fluorescence with a fluorophore that was adsorbed on the 
outer PAH layer.41 In addition to small molecules, macromolecules such as antibodies have been 
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electrostatically attached to polyelectrolytes or covalently attached to the carboxyl group of PAA 
for imaging and therapeutic applications.42-43 
 
1.3.3 Mesoporous Silica Coating 
AuNPs coated by mesoporous silica have drawn great attention. Their silica coating has 
been shown to improve optical properties21 and AuNP colloidal and thermal stability in organic 
solvents. Also, the presence of reactive silanol groups on a silica surface allows for further surface 
modification of AuNPs with biocompatible molecules, drugs, or targeting ligands.44-45 Silica was 
used as a dielectric layer to investigate distance-dependent molecular responses in fluorescence 
emission or Raman intensity near a plasmonic surface.21.46 
 
The Stöber process is the basis for applying mesoporous silica coatings on inorganic NPs. 
The synthesis of silica spheres 0.05 – 2 μm in diameter is controlled through the hydrolysis and 
condensation of tetraalkyl silicates at pH 11-12.47-49 Gorelikov et al. were the first to show the 
direct coating of mesoporous silica on CTAB-coated AuNRs.49 Through modifying the Stöber 
process, sodium hydroxide is added to concentrated AuNRs to adjust the pH to 11. Then 
tetraethylorthosilicate (TEOS) is injected to form silica in a base-catalyzed reaction. This method 
produces 15-nm silica shells in thickness. After this initial coating, additional TEOS could be 
added to the reaction solution, resulting in 60 nm thick non-porous silica shells 
 
Nooney et al. proposed that a mesoporous silica formation on AuNPs involves three stages: 
First, hydrolysis and condensation result in forming silica oligomers. Second, primary 
silica/CTAB particles form. Third, primary particles deposit on silica or CTAB.50 Controlling the 
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growth of mesoporous silica on AuNPs is a complicated process because the silica shell 
morphology is dictated by the surfactant template and the CTAB/silica ratio. We demonstrate that 
one of the most important parameters is the CTAB concentration.21 Though as-synthesized AuNRs 
are typically prepared in 0.1 M CTAB, the concentration of CTAB varies after purification and 
suspension in water. By adjusting the CTAB concentration closer to the critical micelle 
concentration (CMC) from 0.4 – 1.2 mM, we prepared mesoporous silica shells on the AuNRs. 
When the CTAB concentration increases, thinner silica shells form on the AuNRs; while the 
CTAB concentration is higher than the CMC, silica only forms around free CTAB micelles, but 
not on the AuNRs. Further control over the anisotropic growth of silica on AuNRs has been 
demonstrated by Wang et al.51 and us.52 CTAB and TEOS concentrations are carefully controlled 
to allow the preferential deposition of silica on the AuNRs (Figure 1.6). For side silica coatings, 
the oxidation state of thiolated PEG is crucial. Only the PEG-disulfide is effective for selectively 
blocking the ends of AuNRs, leading to side silica coatings. 
 
Figure 1.6. Schematic representation of side silica growth on AuNRs. AuNRs bonded with mPEG-
SH on the ends, resulting in silica growth on the side of rods. Image reprinted with permission 
from ref 52. Copyright 2017 American Chemical Society. 
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1.4 Challenges of Implementing Gold Nanoparticles in Biological Systems 
Despite the fast-approaching biological applications, a fundamental understanding of how 
AuNPs influence biological systems is limited to studies of short-term cytotoxicity,53-55 payload 
of drug delivery and the targeting efficiency of surface modified AuNPs.56-57 Cytotoxicity studies 
provide valuable information on viability, however, lack of the information about physiological or 
behavioral changes accompanied by AuNPs. Increasing evidence suggests that cells up-or down-
regulate certain genes, and change their morphology and behavior in the presence of benign 
AuNPs.58-60 Our previous study showed that subtle changes in the physicochemical properties of 
AuNSs, such as an initial surface charge and surface functionality, influenced the regulation of 
gene expression associated with proliferation, angiogenesis, and metabolism in human dermal 
fibroblasts (HDF).58 Another study showed that while the physicochemical composition of AuNPs 
was kept the same, different cell lines showed distinct behavior after taking up the same AuNPs.59 
For example, the uptake of negatively charged AuNRs promoted migration of HDF; in contrast, 
prostate carcinoma cells (PC3) moved slower after taking up the same AuNRs. We also found that 
a sustained cell stress response was induced after HDF was exposed to a low dose of AuNSs and 
NRs, despite no significant impact on long-term cell viability.61 Therefore, increasing attention 
has been drawn to elucidate the biocompatibility instead of the viability of AuNPs to achieve a 
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CHAPTER 2: MINI GOLD NANORODS WITH TUNABLE PLASMONIC PEAKS1 
 
2.1 Abstract 
 Gold nanorods of small sizes have larger absorption cross sections and higher 
photothermal efficiency compared to larger ones. However, tuning the surface plasmon resonance 
of small gold nanorods remains a challenge because increasing an aspect ratio usually results from 
increasing dimensions. We demonstrate the synthesis of mini gold nanorods with tunable 
longitudinal surface plasmon resonance from ∼600 to > 1300 nm accompanied by precise control 
over widths < 10 nm. Two weak reducing agents, ascorbic acid and even milder hydroquinone, 
were applied to a seed-mediated growth method to tune the aspect ratios of mini gold nanorods 
from 2.2 to 10.8 corresponding to average dimensions 19.3 × 9.0 nm through 93.1 × 8.7 nm, 
respectively. This seed-mediated growth of mini gold nanorods results in an average 96% of rods 
and yields of at least 79% based on gold ion reduction. The extinction coefficients of mini gold 
nanorods were established based on the gold content from inductively coupled plasma mass 
spectrometry. The longitudinal extinction coefficients range from 1.6 × 108 to 1.4 × 109 M−1 cm−1 
depending on aspect ratio. We show that liter-scale mini gold nanorod syntheses are reproducible, 










1 Adapted and reprinted with permission from Chang, H.-H.; Murphy, C. J. Mini Gold Nanorods 
with Tunable Plasmonic Peaks beyond 1000 nm,” Chem. Mater. 2018, 30, 1427-1435. Copyright 




Gold nanoparticles (AuNPs) have been widely used in catalysis,1-3 sensing,4-5 imaging,6-8 
and therapeutics8-10 due to their tunable sizes, tailorable optoelectronic properties, and 
straightforward surface modification.11-15 Most applications of AuNPs rely on their shape- and 
size-dependent plasmonic properties. When resonant light impinges upon AuNPs, free electrons 
oscillate coherently, resulting in a localized surface plasmon resonance (LSPR).16-18 This shape-
dependent LSPR allows the longitudinal LSPR of gold nanorods (AuNRs) to be tunable from the 
visible (Vis) to the near infrared (NIR).16, 19-25 The location of the longitudinal LSPR is influenced 
by particle aspect ratio (AR), which is the length divided by the width of AuNRs. In addition to 
particle shapes, the plasmonic properties of AuNRs are also size-dependent. The scattering-to-
extinction ratio of AuNRs increases with increasing AuNR volume.24-27 Larger AuNRs are better 
for scattering-based applications such as imaging and fluorescence enhancement; smaller AuNRs 
improve photothermal conversion due to higher absorption efficiency.15, 24-28 Fine-tuning AuNR 
sizes is warranted to achieve better control over optical properties of AuNRs.  
 
Although the LSPR of AuNRs is easily tunable, controlling absolute lengths and widths of 
AuNRs remains a challenge. The most widely used procedures for AuNR syntheses are seed-
mediated methods developed by Nikoobakht and El-Sayed29 and us.30 AuNRs made by those 
methods range from 30 to 80 nm in length and 10 to 20 nm in width.19,27,31-35 Larger particles have 
been shown to exhibit slow clearance and low cellular uptake.36-39 Compared to those standard 
AuNRs, mini AuNRs (width < 10 nm) show better photothermal therapy efficiency, higher cellular 




Despite sustained interest in mini AuNRs, the challenge of keeping their small sizes, but 
maintaining tunable plasmonic properties, remains. Mini AuNRs have been synthesized by 
seedless and seed-mediated growth methods.28, 37, 41-44 The seedless method was first reported by 
Ali et al. in 2012.41 Four different dimensions of mini AuNRs were formed in situ while sodium 
borohydride (NaBH4) and cetyltrimethylammonium bromide (CTAB) were used as a reducing 
agent and a surfactant, respectively. The dimensions of those mini AuNRs were tuned by gold, 
silver nitrate (AgNO3) and NaBH4 concentrations in a growth solution at the optimal pH. The 
average lengths of those mini AuNRs ranged from 10 to 27 nm and average widths were all smaller 
than 5.5 nm. The ARs were from 3.3 to 5.0 and longitudinal LSPR peaks were from 700 to 810 
nm. The seedless method was further modified recently by Requejo et al. using 
poly(vinylpyrrolidone) (PVP) as a shape-directing additive to increase the mini AuNR dimensions 
to 45 × 6.7 nm corresponding to AR 6.7.42 In additional to the seedless synthesis, the seed-mediated 
growth of mini AuNRs was shown by Xu et al. and Jia et al.28,44 The longest average length of 
their mini AuNRs was 45 nm; the available ARs ranged from 2.7 to 4.7 and longitudinal LSPR 
peaks were tuned from 726-829 nm.28 
 
Here, we report that the longitudinal LSPR of mini AuNRs can be tuned beyond 1000 nm 
by the seed-mediated growth method. To achieve better control over LSPR positions, we used two 
reducing agents, ascorbic acid and hydroquinone to shift the longitudinal LSPR from ~600 to > 
1300 nm, resulting in mini AuNRs of 9 different ARs (AR 2.2 to AR 10.8). Fine-tuning the ARs 
was achieved through modifying AgNO3, seed, and hydrochloric acid concentrations in the growth 
solution. The average widths of mini AuNRs are all less than 10 nm, but the average lengths 
significantly increase from 19 to 93 nm. Mini AuNR syntheses result in an average shape yield of 
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96% in rods, and > 79% yield compared to initial gold ion concentrations. The extinction 
coefficients of mini AuNRs are reported on a per-particle basis. We demonstrate how to scale up 
mini AuNRs through the synthesis of an extremely large-volume seed solution. Controllable 
dimensions, ARs and shape percent yields were shown in both small-and large-scale mini AuNRs. 
 
2.3 Experimental Section 
2.3.1 Materials 
Cetyltrimethylammonium bromide (CTAB, ≥ 99%), chloroauric acid (HAuCl4 • 3H2O, ≥ 
99.9%), silver nitrate (AgNO3, ≥ 99%), ascorbic acid (ACS grade) and hydroquinone (≥ 99%) were 
purchased from Sigma-Aldrich (USA). Sodium borohydride (NaBH4, ≥ 99%) was acquired from 
Fluka (USA). Hydrochloric acid (HCl, certified 1.0 N) and sodium hydroxide (NaOH, 99.0%) 
were obtained from Fisher Chemical. All chemicals were used as received without further 
purification. 
 
2.3.2 Synthesis of Ascorbic Acid-Reduced Mini AuNRs (Aspect Ratio 2.2 ± 0.6 to 3.8 ± 1.0) 
A seed solution was prepared according to our previous method.19 A gold solution was 
prepared by adding 0.25 mL of 0.010 M HAuCl4 •3H2O to 9.75 mL of 0.10 M CTAB. Ice-cold, 
freshly prepared 0.60 mL of 0.010 M NaBH4 was quickly added to the stirred gold solution. 
Immediately, the solution turned from yellow to yellowish brown. After being vigorous stirring 
for 10 min, the solution was kept unstirred at 27°C for 1.5 h. 
 
To make ascorbic acid-reduced mini AuNRs, aqueous stock solutions of 0.010 M AgNO3 
and 0.10 M ascorbic acid were freshly prepared. All reagents used for mini AuNR syntheses are 
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summarized in Table 2.1. For a typical 10 mL scale synthesis, mini AuNRs of ARs from ~2.2 to 
~3.2 were made by adding 0.50 mL of 0.010 M HAuCl4 •3H2O to 8.0 mL of 0.10 M CTAB. Three 
varied amounts of 0.010 M AgNO3 (0.030, 0.050 and 0.10 mL) were introduced to the growth 
solutions and the solutions were gently inverted. In each solution, 0.20 mL of 1.0 M HCl, 80 μL 
of 0.10 M ascorbic acid, and 2.0 mL of the seed solution were added in sequence and the growth 
solutions were inverted in between. Finally, the solutions were set unstirred for 16-20 h at 27°C 
and were purified on the next day via centrifugation at 16,000xg for 35 min. Colorful supernatant 
was transferred to a new centrifuge tube and purified by the same centrifugation speed and time 
again. Pellets were collected and dispersed in nanopure water for further use. Mini AuNRs of AR 
~3.8 were prepared by the same procedure described above, but with a different growth solution: 
9.0 mL of 0.10 M CTAB, 0.10 mL of 0.010 M AgNO3, and 1.0 mL of the seed solution were used. 
Other solutions were the same as above. 
 






















2.2 ± 0.6 8.0 0.030 N/A 0.20 0.080 N/A 2.0 
2.6 ± 0.7 8.0 0.050 N/A 0.20 0.080 N/A 2.0 
3.2 ± 0.8 8.0 0.10 N/A 0.20 0.080 N/A 2.0 
3.8 ± 1.0 9.0 0.10 N/A 0.20 0.080 N/A 1.0 
5.6 ± 1.3 8.0 N/A 0.040 N/A N/A 0.50 2.0 
8.2 ± 2.3 8.0 N/A 0.040 0.013 N/A 0.50 2.0 
8.7 ± 1.9 8.0 N/A 0.040 0.019 N/A 0.50 2.0 
9.6 ± 2.1 8.0 N/A 0.040 0.025 N/A 0.50 2.0 
10.8 ± 2.8 8.0 N/A 0.040 0.036 N/A 0.50 2.0 
Table 2.1. Summary of reagents used for synthesizing mini AuNRs of 9 aspect ratios. All growth 





2.3.3 Synthesis of Hydroquinone-Reduced Mini AuNRs (Aspect Ratio 5.6 ± 1.3 to 10.8 ± 2.8) 
Seeds for hydroquinone-reduced synthesis were prepared based on procedures developed 
by Vigderman and Zubarev.20 A gold solution containing 0.50 mL of 0.010 M HAuCl4 •3H2O and 
9.5 mL of 0.10 M CTAB was prepared. Next, ice-cold, freshly prepared 0.46 mL of 0.010 M 
NaBH4 in 0.010 M of NaOH was quickly added to the stirred gold solution. Immediately, the 
solution turned from yellow to brown. After being stirred for 10 min, the solution was kept 
unstirred at 27°C for 2 h. 
 
Mini AuNRs of ARs from ~5.6 to ~10.8 were obtained by varying HCl concentrations in 
growth solutions, but a fixed concentration of AgNO3 was used. Stock solutions 0.10 M AgNO3 
and 0.10 M hydroquinone were freshly made. Five 10 mL growth solutions were prepared. Each 
solution contained 0.50 mL of 0.010 M HAuCl4 •3H2O and 8.0 mL of 0.10 M CTAB. Next, 40 
μL of 0.10 M AgNO3 was introduced to each growth solution and the solution was gently inverted. 
Increasing amounts of HCl resulted in higher aspect ratio mini AuNRs: Various amounts of 1.0 M 
HCl (0, 13, 19, 25 and 36 μL) were introduced to the growth solutions and the solutions were 
gently inverted. Then, 0.50 mL of 0.10 M hydroquinone was added to growth solutions and the 
solutions were inverted. Until the solutions turned to completely colorless, 2.0 mL of the seed 
solution was added. Finally, the solutions were set unstirred for 16-20 h at 27°C and were purified 
on the next day via centrifugation at 16,000xg for 35 min. The supernatant was removed; the pellet 






2.3.4 Large-Scale Mini AuNR Synthesis 
Preparation of a 206 mL Gold Seed Solution. To scale up mini AuNRs to ~1 L, a seed 
solution of at least 200 mL is required. First, a solution containing 200 mL and 850 µL of 0.10 M 
CTAB was prepared. Next, 5.15 mL of 0.010 M HAuCl4 •3H2O was added to the CTAB solution. 
Quickly, eight 1.0 mL aliquots and 50 µL of ice-cold, freshly prepared 0.010 M NaBH4 were added 
to the stirred gold solution with a single channel pipette. The solution turned from yellow to 
yellowish brown. After vigorous stirring for 10 min, the solution was kept unstirred at 27°C for 
1.5 h. 
 
Synthesis of Large-Scale Mini AuNRs. A ~1 L mini AuNR growth solution made by 
ascorbic acid reduction was prepared by directly scaling up all solutions. Reagent concentrations 
and temperature were kept the same as those of a 10 mL scale synthesis. To make mini AuNRs of 
AR~2, 50 mL of 0.010 M HAuCl4 •3H2O was added to 0.80 L of 0.10 M CTAB. Next, 3.0 mL of 
0.010 M AgNO3 was introduced to the growth solution and the solution was gently swirled. The 
following solutions were added in sequence and the growth solution was swirled in between: 20 
mL of 1.0 M HCl, 8.0 mL of 0.10 M ascorbic acid, and 0.20 L of the seed solution prepared in the 
previous paragraph. Finally, the solution was set unstirred for 16-20 h at 27°C and was purified on 
the next day via centrifugation at 15,000xg for 20 min. The supernatant was removed, and the 
pellet was dispersed in nanopure water. 
 
2.3.5 Characterization 
UV−vis−NIR spectra were measured with a Cary 5000 UV−vis−NIR spectrophotometer 
(Agilent Technologies, USA). Transmission electron microscopy (TEM) of mini AuNRs was 
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collected by a JEOL 2010 LaB6 or a JEOL 2100 Cryo microscope (JEOL Ltd., Tokyo, Japan). 
Average lengths, widths, ARs and shape percent yields of mini AuNRs were determined by ImageJ 
software (the National Institutes of Health, USA). At least 300 particles were counted to determine 
the dimensions of each batch of mini AuNRs. Inductively coupled plasma mass spectrometry (ICP-
MS) was used to determine the gold concentration of each growth solution. A minimum of three 
measurements were taken for each batch of mini AuNRs by Thermo-Finnigan Element XR ICP-
MS instrument (Thermo Fisher Scientific, USA). 
 
2.4 Results and Discussion 
We report the syntheses of mini AuNRs of different ARs by the seed-mediated approach: 
A seed solution and a growth solution were prepared to separate nucleation and growth steps 
(Figure 2.1). The seed solution used for ascorbic acid-reduced syntheses was identical to that used 
for the standard AuNR synthesis. The major differences between mini and standard AuNR 
syntheses are (i) a dramatic increase in the volume of a seed solution added to the growth solution 
and (ii) a lower pH of the growth solution.28 Figure 2.2a shows the UV−vis−NIR spectra of mini 
AuNRs from AR 2.2 to 2.6, 3.2 and 3.8. Their maximal longitudinal plasmon band wavelengths 
are at 607, 673, 741 and 793 nm, respectively. Increasing AR from 2.2 to 3.2 was achieved by 
increasing AgNO3 concentrations in the growth solutions. This result is consistent with the well-
known method of tuning AuNR ARs by AgNO3.
29 However, the increase in ARs from 3.2 to 3.8 
did not rely on changes of AgNO3 concentrations, but resulted from a decrease in the volume of a 
seed solution added to the growth solution. In both growth solutions, the AgNO3 concentration 
was fixed at 92 µM, but the ratio of a seed to growth solution was decreased from 1:4 to 1:9. Figure 
2.3 shows that mini AuNR ARs can be tuned by gradually decreasing a seed-growth solution ratio 
from 9:1 to 1:9 but with the same AgNO3 concentration. Table 2.2 shows decreasing the seed 
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volume in a growth solution results in the redshifts of UV−vis−NIR spectra. Tuning nanoparticle 
sizes via controlling the amount of seeds in the growth solution has been demonstrated in both 
gold nanosphere and rod syntheses.28, 45 Particles grow smaller when there are more seeds in a 
growth solution. Each seed will receive less Au0 deposition under the limited amount of Au3+ put 
in the growth solution; conversely, particles become larger when fewer seeds are available in the 













Figure 2.2. a) UV−vis−NIR spectra of mini AuNRs from AR 2.2 to 3.8. The blue, green, brown 
and orange spectra correspond to AR 2.2, 2.6, 3.2 and 3.8, respectively. TEM images of ascorbic 
acid-reduced mini AuNRs: AR b) 2.2, c) 2.6, d) 3.2 and e) 3.8.  
28 
 

























Figure 2.3. UV-vis-NIR spectra of ascorbic acid-reduced mini AuNRs made from a seed-growth 
solution ratio 9:1 to 1:9 but with fixed 92 μM of AgNO3.  The black, red, blue, green, pink, orange 




Volume of a seed 
solution in a 10 mL 
growth solution 
9 mL 8 mL 6 mL 5 mL 4 mL 2 mL 1 mL 
Longitudinal LSPR (nm) 
of AuNRs 
671 688 698 715 721 771 793 
Table 2.2 Plasmon maximum wavelengths of CTAB-coated, ascorbic acid-reduced mini AuNRs 




Table 2.3 shows the ARs, dimensions and yields of mini AuNRs made from ascorbic acid-
reduced syntheses. The dimensions, ARs and shape percent yields were calculated based on TEM 
images shown in Figure 2.2b-e. Despite distinct longitudinal plasmon band maxima accompanied 
by increasing AgNO3 concentrations, the lengths of mini AuNRs are very similar: 19.3 ± 4.8, 19.2 
± 5.3 and 20.5 ± 6.5 nm, which correspond to ARs 2.2, 2.6 and 3.2. The effect of AgNO3 on the 
anisotropic growth of mini AuNRs seems less influential in lengths; however, widths decrease 
more obviously from 9.0 ± 1.7 to 6.5 ± 1.3 nm. An inverse correlation is shown between increases 
in the amount of AgNO3 and decreases in the widths, resulting in increasing ARs. The reduction 
yields of ascorbic acid-reduced mini AuNRs are at least 79%, which is significantly higher than ~ 








2.2 ± 0.6  607 19.3 ± 4.8 9.0 ± 1.7 96.7 (N = 514) 79 
2.6 ± 0.7  673 19.2 ± 5.3 7.6 ± 1.7 96.1 (N = 672) 81 
3.2 ± 0.8  771 20.5 ± 6.5 6.5 ± 1.3 89.6 (N = 824) 89 
3.8 ± 1.0  793 21.7 ± 5.5 5.8 ± 0.8 96.7 (N = 519) 87 
Table 2.3. Aspect ratios (ARs), dimensions, and shape percent yield and gold yield of ascorbic 
acid-reduced mini AuNRs. The shape percent is defined by 
# of NRs
# of all shapes
 × 100%. N refers to the 
number of particles measured. Triplicate measurements for metal concentrations were taken by 
ICP-MS. The standard deviations of the gold concentrations from AuNRs are less than 0.08%.  
Yield is calculated from ICP-MS data for initial gold concentration in the growth solution 





          To achieve higher ARs, the weaker reducing agent hydroquinone was used instead of 
ascorbic acid.20 Mini AuNRs of AR 5.6-10.8 were prepared by tuning HCl concentrations in the 
growth solutions under a fixed AgNO3 concentration. The concentration of HCl varied from 0 to 
3.3 mM, but the AgNO3 concentration was fixed at 0.36 mM for all growth solutions. Figure 2.4a 
shows the normalized extinction spectra of hydroquinone-reduced mini AuNRs made from 
different HCl concentrations. Increasing the amounts of HCl in the growth solutions resulted in 
gradual redshifts of longitudinal LSPR peaks: the plasmon bands shifted from 875 to 1040, 1167, 
1245 and > 1300 nm. Figure 2.4b-e and Table 2.4 show that the dimensions and ARs of 
hydroquinone-reduced mini AuNRs increase with increasing the HCl concentration in the growth 
step. The lengths of hydroquinone-reduced mini AuNRs, unlike ascorbic acid-reduced ones, 
increase significantly from 27.2 ± 4.4 to 93.1 ± 18.3 nm. The average widths also increase; 
however, all are precisely controlled within 10 nm (from 5.0 ± 0.5 to 8.7 ± 1.0 nm). The ARs of 
hydroquinone-reduced mini AuNRs are tunable by changing the HCl concentration in the growth 
solutions. The smallest AR is 5.6 obtained by no HCl in the growth solution. The largest AR 10.8 
resulted from introducing the highest amount of HCl to the growth solution. These dimensions 
93.1 ± 18.3 × 8.7 ± 1.0 nm are unique since reported AuNRs with similar lengths are larger than 
20 nm in width.20, 22-23, 47 All Hydroquinone-reduced mini AuNRs render high shape percent yields 













Figure 2.4. a) UV−vis−NIR spectra of mini AuNRs from AR 5.6 (red) to 8.2 (blue), 8.7 (yellow), 
9.6 (green) and 10.8 (pink). TEM images of hydroquinone-reduced mini AuNRs: AR b) 5.6, c) 
















Shape percent yield Yield 
(%)  
5.6 ± 1.3 875 27.2 ± 4.4 5.0 ± 0.5 96.4 (N = 345) 91 
8.2 ± 2.3 1040 48.4 ± 9.6 6.0 ± 0.7 97.0 (N = 334) ~100 
8.7 ± 1.9 1167 51.9 ± 9.3 6.0 ± 0.7 96.7 (N = 428) ~100 
9.6 ± 2.1 1245 58.7 ± 10.8 6.2 ± 0.7 98.8 (N = 330) ~100 
10.8 ± 2.8 > 1300 93.1 ± 18.3 8.7 ± 1.0 95.9 (N = 362) ~100 
Table 2.4. Aspect ratios (ARs), dimensions, and shape percent yield and gold yield of 
hydroquinone-reduced mini AuNRs. The shape percent is defined by 
# of NRs
# of all shapes
 × 100%. N 
refers to the number of particles measured. Triplicate measurements for metal concentrations were 
taken by ICP-MS. The standard deviations of the gold concentrations from AuNRs are less than 
0.08%.  Yield is calculated from ICP-MS data for initial gold concentration in the growth solution 
compared to gold concentration in aqua regia-digested metal nanoparticle solutions. 
 
The HCl concentration in the growth solution is crucial, since the hydroquinone reduction 
potential is pH-dependent.48-49 We observed that different HCl concentrations in the growth 
solutions, indeed, tuned the final AuNR ARs, but a further increase of the HCl concentration (from 
3.3 to 4.5 mM) increases neither the lengths, widths nor ARs of hydroquinone-reduced mini 
AuNRs. The average lengths and widths of hydroquinone-reduced mini AuNRs made from 3.3 
and 4.5 mM of HCl are similar: 93.1 ± 18.2 and 92.6 ± 18.3 nm in length and 8.7 ± 1.0 and 8.7 ± 










Figure 2.5. a) UV-vis-NIR spectra of hydroquinone-reduced mini AuNRs made from 3.3 and 4.5 
mM of HCl. All growth solutions contained 0.36 mM of AgNO3. TEM image of mini AuNRs 







Length (nm) Width (nm) Shape percent yield  
3.3 10.8 ± 2.8 > 1300 93.1 ± 18.2 8.7 ± 1.0 95.9 (N = 362) 
4.5 10.8 ± 2.8 > 1300 92.6 ± 18.3 8.7 ± 1.1 95.9 (N = 410) 
Table 2.5. Comparison of ARs, dimensions, and the shape percent yields of hydroquinone-reduced 








For standard AuNRs, it is well-known that the aspect ratio of the particles is tuned by the 
concentration of AgNO3: When there is more silver in the growth solution, the aspect ratio is 
higher.29,30 The effect of AgNO3 on the ARs of hydroquinone-reduced mini AuNRs was 
investigated in the absence and presence of HCl. When no HCl was in the growth solutions, 
hydroquinone-reduced mini AuNRs were not tunable by AgNO3: The maximum wavelengths only 
shift from 772 to 881 nm despite increases of AgNO3 concentrations from 0.091 to 0.36 mM 
(Figure 2.6). No linear relationship between increases in the AgNO3 concentration and the 
longitudinal plasmon band maximum was found, in contrast to the “standard” synthesis (Table 
2.6). However, in the presence of HCl, the correlation between the AgNO3 concentration in the 
growth solution and the position of the longitudinal plasmon band is linear (Figure 2.7). 
Ultimately, longitudinal LSPR peaks showed continual redshifts from 673 to 989, 1242 and > 1300 
nm in the presence of 2.3 mM of HCl with increasing AgNO3 concentration (Table 2.7). Although 
the longitudinal LSPR peaks are tunable by varying AgNO3 concentrations, many byproducts 
appear in the growth solutions when the AgNO3 concentrations were low (Figure 2.7). The 
plasmon band tunability of hydroquinone-reduced mini AuNRs relies more on the presence of HCl 
than AgNO3 in the growth solutions, for reasons that are not yet clear.  Possibilities include (i) the 
pH-dependent reduction potential of hydroquinone, (ii) the chloride counterion that can form 
AgCl(s) and AgCl2
- complex ions under our conditions.  Recent work in the literature suggests that 
silver underpotential deposition on specific crystal facets, mediated by the presence of complexing 
ions, might be the symmetry-breaking foundation of nanorod formation;50 therefore, silver-
chloride complexes may require chloride from HCl in addition to chloride from HAuCl4. 
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 0.091 mM of AgNO3
 0.18 mM of AgNO3
 0.27 mM of AgNO3
 0.36 mM of AgNO3
 
Figure 2.6. UV-vis-NIR spectra of hydroquinone-reduced mini AuNRs made from various 




Concentration of AgNO3 (mM) 0.091 0.18 0.27 0.36 
Longitudinal LSPR (nm) of AuNRs 772 881 838 824 
Table 2.6. Plasmon maximum wavelengths of CTAB-coated, hydroquinone-reduced mini 






Figure 2.7. a) UV-vis-NIR spectra of hydroquinone-reduced mini AuNRs made from various 
concentrations of AgNO3. All growth solutions contain 2.3 mM of HCl. TEM images of mini 





Concentration of AgNO3 (mM) 0.091 0.18 0.27 0.36 
Longitudinal LSPR (nm) of AuNRs 673 989 1242 > 1300 
Table 2.7. Plasmon maximum wavelengths of CTAB-coated, hydroquinone-reduced mini AuNRs 
resulted from increasing the concentration of AgNO3 in growth solutions. All growth solutions 
contain 2.3 mM of HCl. 
 
Figure 2.8 shows the linear relationship between ARs of mini AuNRs and the 
corresponding maximal longitudinal plasmon band wavelengths. The standard deviations in ARs 
become significantly larger as ARs increase beyond 8.2. We did not include AR 10.8 on Figure 
2.8 because the maximal wavelength is larger than 1300 nm, which is not spectroscopically 
detectable due to water absorption. The average widths are all less than 10 nm as shown in Figure 
2.8b. The average widths of mini AuNRs decrease as ARs increase from 2.2 to 5.6; the widths, 
however, increase as ARs increase from 5.6 to 10.8. Figure 2.8c shows the correlation between 




Figure 2.8. a) Linear relationship between the ARs of mini AuNRs and the corresponding 
longitudinal plasmon band wavelengths; R2 = 0.96984. Plots of (b) mini rod widths versus AR and 
(c) mini rod lengths versus AR, for AR 2.2-10.8.  
 
Table 2.8 shows extinction coefficients of mini AuNRs from AR 2.2 to 10.8, from ICP-
MS detection of metal ions from aqua-regia digested rods in concert, and assuming the bulk face-
centered-cubic (fcc) crystal structure of gold with a = 4.08 Å. The longitudinal extinction 
coefficients range from 1.6 × 108 to 1.4 × 10
9 M-1cm-1. Mini AuNRs of ARs less than 5.6 show 10-
fold smaller extinction coefficients (~2 × 108 M
-1cm-1) compared to those of standard AuNRs (2.5-
5.5 × 109 M-1cm-1).46 The results, are consistent with the extinction coefficient 1.9 × 108 M
-1cm-1 
(AuNRs with dimensions 25 × 5 nm) reported by Ali et al.40 As the AR increases to 8.2, the 
extinction coefficient of mini AuNRs increases to 1.4 × 109 M-1cm-1. This magnitude is still smaller 
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than the smallest extinction coefficient of standard AuNRs (2.5 × 109 M-1cm-1) due to the relatively 




















2.2 ± 0.6  523 3 ± 1 × 10
8
   607 3 ± 1 × 10
8
   
2.6 ± 0.7  514 1.1 ± 0.5 × 10
8
  673 1.6 ± 0.7 × 10
8
  
3.2 ± 0.8  507 9 ± 4 ×10
7
 771 2 ± 1 × 10
8
   
3.8 ± 1.0  507 7 ± 2 × 10
7
 793 2.0 ± 0.7 × 10
8
  
5.6 ± 1.3 507 8 ± 2 × 10
7
 875 2.9 ± 0.6 × 10
8
  
8.2 ± 2.3 504 1.8 ± 0.5 × 10
8
  1040 9 ± 2 × 10
8
 
8.7 ± 1.9 504 1.8 ± 0.5 × 10
8
  1167 1.0 ± 0.3 × 10
9
  
9.6 ± 2.1 504 2.4 ± 0.6 × 10
8
  1245 1.4 ± 0.3 × 10
9
  
10.8 ± 2.8 504 7 ± 2 × 10
8
 > 1300 N/A 
Table 2.8. Transverse and longitudinal extinction coefficients of mini AuNRs from AR 2.2 to 
10.8. Extinction coefficients are reported on a per-particle basis and include the standard deviations 
in particle dimensions (which is larger than the standard deviation in metal content). 
 
 
Figure 2.9 shows single-area electron diffraction data for ascorbic acid- and hydroquinone-
reduced mini AuNRs. Unlike our original penta-twinned rods, the materials are single crystalline.51 
Two planes (200) and (220) were identified in mini AuNRs of AR 3.2 with interplanar spacings 
d200 = 0.2042 nm and d220 = 0.1424 nm, which correspond to the reported values of fcc gold d200 
= 0.2039 nm and d220 = 0.1442 nm, respectively (Joint Committee on Powder Diffraction 
Standards, No. 04-0784). In addition to (200) and (220), two planes (111) and (222) show in mini 
AuNRs of AR 5.6. Interplanar spacings d111= 0.2234 nm in Figure 2.9c and d222 = 0.1116 nm in 
Figure 2.9b agree with the fcc structure of metallic gold d111= 0.2355 nm and d222 = 0.1177 nm. 
Interplanar angles are (200) ˄  (220) = 45.5° in Figure 2.9a, (200) ˄  (222) = 84.1° and (222) ˄  (422) 
= 26.1° in Figure 2.9b, (200) ˄ (111) = 55.3° and (111) ˄ (220) = 38.2° in Figure 2.9c. Interplanar 
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angles (200) ˄ (220) = 45.5°, (200) ˄ (111) = 55.3° and (111) ˄ (220) = 38.2° correspond well to 






Figure 2.9. Single-crystallinity of ascorbic acid-and hydroquinone-reduced mini AuNRs. a) 





We achieved mini AuNRs from AR 2.2 to AR 10.8 on a small scale (a 10 mL growth 
solution). However, the challenge of a large-scale synthesis of mini AuNRs arises from the 
necessity of a significant increase in seed solution volume. To make 10 mL of mini and standard 
AuNR growth solutions, 2 mL and 12 µL of seed solutions are required, respectively. Scaling up 
mini AuNRs to a 400 mL growth solution thus needs an 80 mL seed solution. This is an enormous 
amount compared to the 480 µL of seeds to make 400 mL of standard AuNRs. Through modifying 
the concentration of NaBH4, we demonstrate how to make seed solutions up to 206 mL (see 
Experimental Section 2.3.4). The ranges of NaBH4 concentrations required to produce acceptable 
seed solutions from 21 to 206 mL are summarized in Figure 2.10a. As the volume of a seed solution 
becomes larger, the acceptable range of NaBH4 concentrations becomes narrower: To make a mini 
AuNR growth solution that produces > 90% shape percent yields, the acceptable NaBH4 
concentrations are 0.37-0.41 mM for a 21 mL seed solution, but only 0.376 mM of NaBH4 
produces a 206 mL seed solution. Figure 2.10b and c show CTAB-capped Au seeds made from 10 
and 206 mL of seed solutions. Their morphology and sizes are similar. Sizes for seeds made from 
10 and 206 mL of seed solutions are 1.9 ± 0.5 nm (N = 392) and 1.5 ± 0.4 nm (N = 422), 




Figure 2.10. a) Ranges of NaBH4 concentrations required to produce acceptable seed solutions 
from 21 to 206 mL. TEM image of CTAB-capped Au seeds made from b) 10 mL and c) 206 mL 
of seed solutions. 
 
We sought to compare the relative abilities of small- and large-scale seeds to grow 
monodisperse rods. Below shows the result of ascorbic acid-reduced mini AuNRs from two 10 
mL growth solutions. One growth solution was made from a standard 10 mL seed solution and the 
other was synthesized from a 206 mL seed solution. All growth solutions contained 46 µM of 
AgNO3, aiming for AR ~2.6. Figure 2.11 shows UV−vis−NIR spectra of ascorbic acid-reduced 
mini AuNRs made from 10 and 206 mL of seed solutions. Their maximum wavelengths are 
similar: The former is at 658 nm and the latter at 650 nm. Figure 2.11b and c show the TEM images 
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of mini AuNRs made from 10 and 206 mL of seed solutions, respectively. Their lengths, widths, 
ARs and shape percent yields are all very comparable as shown in Table 2.9: 19.2 ± 5.3 and 19.6 
± 4.3 nm in length, 7.6 ± 1.7 and 8.0 ± 1.7 in width, and 2.6 ± 0.7 and 2.5 ± 0.7 in AR. Consistent 
with the UV−vis−NIR, mini AuNRs made from the 206 mL seed solution show smaller standard 
deviations of the dimensions and a slightly higher shape percent yield. 
 
 
Figure 2.11. a) UV−vis−NIR spectra of two 10 mL of mini AuNRs made from 10 and 206 mL of 





Mini AuNRs made 








AR Shape percent 
yield 
10 mL 658 19.2 ± 5.3 7.6 ± 1.7 2.6 ± 0.7 96.1 (N = 672) 
206 mL 650 19.6 ± 4.3 8.0 ± 1.7 2.5 ± 0.7 97.6 (N = 336) 
Table 2.9. Aspect ratios (ARs), dimensions, and the shape percent of two 10 mL of mini AuNRs 
made from 10 and 206 mL of seed solutions. The shape percent yield is defined by 
# of NRs
# of all shapes
 × 
100%. N refers to the number of particles been measured. 
 
 
            It has been shown in the previous section that mini AuNRs made from 10 and 206 mL of 
seed solutions are comparable. With this large amount of the seed solution, 1 L of the mini AuNR 
growth solution should be possible. Each 10 mL growth solution of mini AuNRs requires 2 mL of 
a seed solution. Therefore, with a 206 mL seed solution, 1.03 L of a mini AuNR growth solution 
can be made. Also, more than 170 L of a growth solution containing standard AuNRs could be 
made because each 10 mL growth solution only needs 12 µL of a seed solution. We did not 
synthesize 170 L of standard rods due to the complexity of making such a large scale in the lab, 







Three individual 1 L mini AuNR growth solutions were synthesized to test the 
reproducibility of large-scale mini AuNRs and were compared to a small-scale synthesis (10 mL 
growth solutions). To compare the reproducibility of 1 L mini AuNRs, all growth solutions were 
prepared by the ascorbic acid-reduced method and contained 28 µM of AgNO3 (aiming for AR 
~2.2), but made from three individual 206 mL of the seed solutions on different days. The UV-
vis−NIR spectra of those trials are shown in Figure 2.12a. Figure 2.12b-d show the TEM images 
of mini AuNRs from three 1 L batches. All three batches have widths less than 10 nm and shape 
percent yields higher than 97% (Table 2.10). Although there are some slight differences in the 
maximum wavelengths, ARs, and lengths between batches, the average dimension, AR and shape 
percent yield are comparable to mini AuNR of AR 2.2 from a 10 mL synthesis (Table 2.3). 1 L 
batch renders an average concentration of 1.1 × 10-7 M of mini AuNRs, which can be further 
reconstituted to form micromolar concentration sufficient for most biological applications.  We 
demonstrate large-scale mini AuNRs were reproducible with respect to controlling widths less 






Figure 2.12. a) UV−vis−NIR spectra of mini AuNRs from three 1 L batches. b)-d) TEM images 





















































































































































































































































































































































































































































































































































We demonstrate how to make mini AuNRs with a wide range of ARs from 2.2 to 10.8 by 
a seed-mediated growth approach. Their longitudinal LSPR can be finely tuned from ~600 to > 
1300 nm through changes of reducing agents and modifying AgNO3, HCl and seed concentrations 
in the growth solution. Despite the lengths of mini AuNRs ranging from 19 to 93 nm, precise 
control over widths has been shown: All were less than 10 nm. This seed-mediated growth of mini 
AuNRs offers high gold ion reduction (> 79%) compared to ~ 15% yield from the standard AuNR 
synthesis.45 Scaling up mini AuNRs to 1 L has been achieved through an extremely large volume 
seed solution, producing comparable mini AuNRs as the small-scale synthesis. This large volume 
seed solution also benefits other AuNR syntheses. We have shown that large-scale synthesis of 
mini AuNRs is reproducible with the controllable widths and ARs along with high shape percent 
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Gold nanorods are widely used in many biomedical applications. The size and shape of 
gold nanorods influence not only their optoelectronic properties, but also cellular uptake and 
removal. To understand how the size of gold nanorods affects endo- and exocytosis, we prepared 
gold nanorods with four distinct dimensions accompanied by three different aspect ratios (2.6, 5.2 
and 9.7), but all were of the same surface chemistry (poly(ethylene glycol)). We found that 
regardless of the same aspect ratio, gold nanorods of different dimensions show different cellular 
uptake by primary human pulmonary artery endothelial cells.  Gold nanorods with smaller 
dimensions were taken up twofold more than their counterpart of the same aspect ratio. This size-
dependent endocytosis, however, is not determined by the dimensions. We found a negative 
correlation between cellular uptake of gold nanorods and rod widths. Gold nanorods with average 
widths less than 10 nm, despite the highest aspect ratio, were endocytosed more than those with 
average widths larger than 10 nm. We also investigated the exocytosis of gold nanorods in a 10 h 
interval. Our result shows that > 75% of gold nanorods were removed from primary human 










Gold nanoparticles (AuNPs) are widely used in biomedical applications, such as imaging,1-
3 sensing,4-5 drug delivery and photothermal therapy.6-8 Most these applications of AuNPs rely on 
their shape- and size-dependent plasmonic properties called a localized surface plasmon resonance 
(LSPR),9-11 which arises from free electrons upon the AuNPs oscillating coherently with the 
electric field of the light.   Unlike gold nanospheres (AuNSs) with only one LSPR, the additional 
longitudinal LSPR of gold nanorods (AuNRs) allows their plasmonic properties to be tunable from 
the visible (Vis) to the near infrared (NIR).9, 12-18 The size and shape of AuNPs not only influence 
their optoelectronic properties, but also NP cellular uptake and removal. To improve diagnostic 
sensitivity, and drug release and photothermal efficiency, it is imperative to understand how the 
physicochemical properties of NPs (size, shape, charge and surface chemistry) interact with cells 
from initial cellular uptake to secretion.  
 
The size-dependent cellular uptake of AuNPs has been observed in many studies. Chithrani 
and Chan found that transferrin-coated AuNSs of 50 nm showed the maximal uptake throughout 
mouse fibroblast STO cells, human cervical cancer (HeLa) cells and human glioblastoma cells 
(SNB-19).19 This size-dependent cellular uptake of AuNPs was also demonstrated by Yue et al. 
showing 50-nm AuNSs conjugated by small interfering RNA were taken up the most by human 
primary glioblastoma cells (U87).20 This optimal size of AuNSs were confirmed by many 
theoretical studies, which consider the interactions between cellular receptors and ligands of 
colloidal particles by kinetics and thermodynamic models.21-22 In contrast to the consistent results 
of the optimal size for AuNS cellular uptake, different conclusions of how AuNR sizes influence 
endocytosis were drawn.  Chithrani and Chan have shown that transferrin-coated AuNR cellular 
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uptake decreased with increasing aspect ratio (AR) in mouse fibroblast STO cells, human cervical 
cancer (HeLa) cells and human glioblastoma cells (SNB-19).19 The AR is the ratio of the length to 
the width of AuNRs. This result was also observed by another group using poly(ethylene glycol) 
(PEG)-coated NRs with a different cell line mouse endothelial cells (C166).23 Yang et al. showed 
that NR uptake decreased with increasing ARs and the NRs of the smallest AR shown the highest 
uptake. However, Kinnear et al. observed no effects of AR on endocytosis when 
polyvinylpyrrolidone-coated AuNRs with ARs less than 5 in human lung 
epithelial carcinoma cells (A549), Hela cells and J774A.1 macrophages.24 Moreover, AuNRs with 
the AR larger than 5 were preferentially endocytosed by A549 and Hela cells. 
 
To understand how the size of AuNRs contributes to cellular uptake and removal, we 
correlated each parameter of sizes (width, length, AR and volume) with endo- and exocytosis of 
NRs. We prepared AuNRs with four distinct dimensions, of which there were three different aspect 
ratios (2.6, 5.2 and 9.7), but all were of the same surface chemistry (methoxy PEG-thiol (mPEG-
SH)). We found that regardless of the same AR, AuNRs of different dimensions show different 
cellular uptake by primary human pulmonary artery endothelial cells (HPAEC). AuNRs of the 
smaller dimensions were endocytosed twofold more compared to those of larger dimensions, but 
of the same AR. We found a low correlation (R2 = 0.17969) exists between the endocytosis of 
AuNRs and rod volumes. Also, the cellular uptake of AuNRs is relatively independent of rod 
lengths and ARs (R2 < 0.12). We, however, found a negative correlation (R2 = 0.6501) between 
the cellular uptake of AuNRs and rod widths. Although their AR was the highest, AuNRs with an 
average width less than 10 nm were endocytosed more than those with average widths larger than 
10 nm. This shows that the cellular uptake of AuNRs depends more on the widths rather than the 
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lengths, ARs and volumes of rods. We also investigated AuNR exocytoses in a 10 h interval. Our 
result shows that at the end of 10 h, > 75% of rods were removed from HPAEC.  
 
3.3 Experimental Section 
 
3.3.1 Materials 
AuNR Syntheses. Cetyltrimethylammonium bromide (CTAB, ≥ 99%), chloroauric acid 
(HAuCl4 • 3H2O, ≥ 99.9%), silver nitrate (AgNO3, ≥ 99%), ascorbic acid (ACS grade) and 
hydroquinone (≥ 99%) were purchased from Sigma-Aldrich. Sodium borohydride (NaBH4, ≥ 99%) 
was acquired from Fluka. Hydrochloric acid (HCl, certified 1.0 N) and sodium hydroxide (NaOH, 
99.0%) were obtained from Fisher Chemical. Methoxy poly(ethylene glycol) thiol (mPEG-SH, 
5000 M.W.) was purchased from NanoCS. All chemicals were used as received without further 
purification. 
 
Cell Culture. Primary human pulmonary artery endothelial cells (HPAEC), endothelial cell 
basal medium-2 (EBMTM-2), endothelial cell growth medium-2 (EGMTM-2) 
SingleQuotsTM Supplements, Trypsin/EDTA solution (0.025%) and phosphate buffered saline 
(PBS, without calcium and magnesium) were purchased from Lonza. Fetal bovine serum (FBS, 
sterile-filtered) was purchased from Millipore Sigma. Potassium iodide (KI, granular, free flowing, 
certified ACS) was obtained from Fisher Chemical. Trypan blue solution (0.4%) was obtained 
from Invitrogen. Iodine (I2, 99.99+%) and triton X-100 (laboratory grade) were purchased from 





3.3.2 Synthesis of Ascorbic Acid-Reduced Mini AuNRs (Aspect Ratio 2.6 ± 0.7) 
Preparation of an 87 mL Gold Seed Solution. To prepare ~400 mL of mini AuNRs, a seed 
solution of at least 80 mL is required. First, a solution containing 81.9 mL of 0.10 M CTAB was 
prepared. Next, 2.1 mL of 0.010 M HAuCl4 •3H2O was added to the CTAB solution. Quickly, 
three 1.0 mL aliquots and 283 µL of ice-cold, freshly prepared 0.010 M NaBH4 were added to the 
stirred gold solution with a single channel pipette. The solution turned from yellow to yellowish 
brown. After vigorous stirring for 10 min, the solution was kept unstirred at 27°C for 2 h. 
 
Synthesis of Large-Scale Mini AuNRs. Aqueous stock solutions of 0.010 M AgNO3 and 
0.10 M ascorbic acid were freshly prepared. To make mini AuNRs of AR~2.6, 20 mL of 0.010 M 
HAuCl4 •3H2O was added to 320 mL of 0.10 M CTAB. Next, 2.0 mL of 0.010 M AgNO3 was 
introduced to the growth solution and the solution was gently swirled. The following solutions 
were added in sequence and the growth solution was swirled in between: 8.0 mL of 1.0 M HCl, 
3.2 mL of 0.10 M ascorbic acid, and 80 mL of the seed solution prepared in the previous paragraph. 
Finally, the solution was set unstirred for 16-20 h at 27°C and was purified on the next day via 
centrifugation at 15,000xg for 20 min. The supernatant was removed, and the pellet was dispersed 
in nanopure water. 
 
3.3.3 Synthesis of Ascorbic Acid-Reduced Standard AuNRs (Aspect Ratio 2.6 ± 0.6) 
Preparation of a 10 mL Gold Seed Solution. A seed solution was prepared according to our 
previous method.12 A gold solution was prepared by adding 0.25 mL of 0.010 M HAuCl4 •3H2O 
to 9.75 mL of 0.10 M CTAB. Ice-cold, freshly prepared 0.60 mL of 0.010 M NaBH4 was quickly 
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added to the stirred gold solution. Immediately, the solution turned from yellow to yellowish 
brown. After being vigorous stirring for 10 min, the solution was kept unstirred at 27°C for 1.5 h. 
 
Synthesis of Large-Scale Standard AuNRs. To make ~1 L standard AuNRs with AR ~2.6, 
0.010 M of AgNO3 and 0.10 M of ascorbic acid were freshly prepared. First, 50 mL of 0.010 M 
HAuCl4 •3H2O was added to 950 mL of 0.10 M CTAB to make a growth solution. After 3.0 mL 
of 0.010 M AgNO3 was introduced to the growth solution and the solution was gently swirled. 
Then, 5.5 mL of 0.10 M ascorbic acid was added to the growth solution and the solution changed 
to colorless upon mixing. Finally, 1.2 mL of seed solution was added to the growth solution and 
the solution was set unstirred for 16-20 h at 27°C. AuNRs were purified by centrifugation at 
11,200xg for 20 min. The supernatant was removed, and the pellet was dispersed in nanopure 
water 
 
3.3.4 Synthesis of Hydroquinone-Reduced AuNRs (Aspect Ratio 5.2 ± 1.1) 
Preparation of a 10 mL Gold Seed Solution. Seeds for hydroquinone-reduced synthesis 
were prepared based on procedures developed by Vigderman and Zubarev.13 A gold solution 
containing 0.50 mL of 0.010 M HAuCl4 •3H2O and 9.5 mL of 0.10 M CTAB was prepared. Next, 
ice-cold, freshly prepared 0.46 mL of 0.010 M NaBH4 in 0.010 M of NaOH was quickly added to 
the stirred gold solution. Immediately, the solution turned from yellow to brown. After being 
stirred for 10 min, the solution was kept unstirred at 27°C for 2 h. 
 
Synthesis of Large-Scale Hydroquinone-Reduced AuNRs. To make ~0.5 L of AuNRs with 
AR ~5.2, stock solutions 0.10 M AgNO3 and 0.10 M hydroquinone were freshly made. A growth 
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solution contained 25 mL of 0.010 M HAuCl4 •3H2O and 475 ml of 0.10 M CTAB. Next, 1.0 mL 
of 0.10 M AgNO3 was introduced to the growth solution and the solution was swirled. Then, 25 
mL of 0.10 M hydroquinone was added to the growth solution and the solution was swirled again. 
Until the solution turned to completely colorless, 8.0 mL of the seed solution was added, and the 
solution was mixed well. Finally, the solution was set unstirred for 16-20 h at 27°C and was 
purified on the next day via centrifugation at 4,500xg for 20 min. The supernatant was removed, 
and the pellet was dispersed in nanopure water.  
 
3.3.5 Synthesis of Hydroquinone-Reduced Mini AuNRs (Aspect Ratio 9.7 ± 2.3) 
Preparation of a 42 mL Gold Seed Solution. A seed solution of at least 40 mL is required 
for preparing ~400 mL of mini AuNRs with AR ~9.7. To make a 42 mL seed solution, a gold 
solution containing 2.0 mL of 0.010 M HAuCl4 •3H2O and 38 mL of 0.10 M CTAB was prepared. 
Next, ice-cold, freshly prepared two 1.0 mL aliquots and 30 µL of 0.010 M NaBH4 in 0.010 M of 
NaOH was quickly added to the stirred gold solution. Immediately, the solution turned from yellow 
to brown. After stirred for 10 min, the solution was kept unstirred at 27°C for 2 h. 
 
Synthesis of Large-Scale Hydroquinone-Reduced Mini AuNRs. Stock solutions 0.10 M 
AgNO3 and 0.10 M hydroquinone were freshly made for synthesizing ~400 mL of mini AuNRs 
with AR 9.7. A growth solution contained 20 mL of 0.010 M HAuCl4 •3H2O and 360 mL of 0.10 
M CTAB. Next, 1.6 mL of 0.10 M AgNO3 was introduced to the growth solution and the solution 
was swirled. To increase the AR, 1.0 mL of 1.0 M HCl was introduced to the growth solution and 
the solution was mixed well. Then, 20 mL of 0.10 M hydroquinone was added to the growth 
solution and the solution was swirled. Until the solution turned to completely colorless, 40 mL of 
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the seed solution was added. Finally, the solution was set unstirred for 16-20 h at 27°C and was 
purified on the next day via centrifugation at 16,000xg for 30 min. The supernatant was removed, 
and the pellet was dispersed in nanopure water.  
 
3.3.6 Methoxy PEG Thiol Functionalization of AuNRs 
To prepare mPEG-SH functionalized mini AuNRs, 1.0 mL of 10 nM mini AuNRs with AR 
2.6 was centrifuged at 11,000xg for 20 min. After centrifugation the supernatant was removed. A 
concentrated pellet was added dropwise to 0.50 mL of 20 mg/mL mPEG-SH solution. Then, the 
solution was mixed well and put on a shaker for 20 h. On the next day, the solution was centrifuged 
at 11,000xg for 20 min. The supernatant was removed, and the pellet was dispersed in 0.50 mL of 
nanopure water. To remove free mPEG-SH in the solution, the solution was centrifuged at 
11,000xg for 20 min again. After the supernatant was removed, the pellet was dispersed in 
nanopore water and the solution was sonicated for 10 min. PEGylated AuNRs of other ARs were 
prepared by the same procedure described above, but with different AuNR concentrations and 
centrifugation speed and time. Detailed experimental conditions used for mPEG-SH 
functionalization of AuNRs are summarized in Table 3.1. To sterilize mPEG-SH functionalized 
AuNRs, all AuNRs by were passed through sterile, 0.22-µm, surfactant-free, cellulose acetate 


























AuNR concentration (nM)   10 6 4 4 
Centrifugation speed and 
time after initial 
purification 
11,000xg 
for 20 min 
11,000xg 
for 20 min 
4,500xg for 15 min 11,000xg 
for 20 min 
Centrifugation speed and  
time after PEGylation 
11,000xg 
for 20 min 
6,000xg for 
20 min 
2,000xg for 20 min 6,000xg for 
20 min 
Table 3.1. Summary of experimental conditions used for PEGylation of AuNRs with three aspect 
ratios. 
 
3.3.7 Cell Culture  
HPAEC from a non-smoking, 58-year-old, Caucasian male donor was cultured in 
endothelial cell growth medium-2 (EGM-2) supplemented with 10 v/v% of FBS. To formulate 
EGM-2, EGMTM-2 SingleQuotsTM was added to EBMTM-2. HPAEC was cultured in a 37
°C 
humidified incubator with 5% CO2 according to manufacturer’s protocol. Passage 5 was used for 
all experiments. The seeding efficiency of this batch of HPAEC was 81% with doubling time of 
22 h determined by Lonza, Inc. 
 
3.3.8 Stability of AuNRs in Cell Culture Medium 
To make mPEG-SH functionalized AuNRs stable in EGM-2 with 10 v/v% of FBS, 
AuNRs were added to 1 v/v% of FBS at room temperature. After AuNRs were incubated with 
FBS for 40 min, EGM-2 with 10 v/v% of FBS was added to the incubated AuNRs. 1 v/v% of 
FBS means when AuNRs mixed with EGM-2 with 10 v/v% of FBS, the additional concentration 




3.3.9 AuNR Exposure  
HPAEC was seeded at 1.2 × 104 cells/well with 200 µL of EGM-2 with 10 v/v% of FBS in 
a 48-well tissue culture plate. To examine how HPAEC viability was affected by 1) AuNRs, 2) 
additional FBS in the cell culture media and 3) an I2/KI etchant, we exposed HPAEC to seven 
different conditions, including four samples and three additional controls. All samples and controls 
were performed in triplicate. After HPAEC was seeded for 22 h, cell density increased to 2.4 × 
104 cells/well. First, we removed sample well media and exposed each HPAEC to 1.0 × 10-20 moles 
of FBS-coated, PEGylated AuNRs. Meanwhile, the media of control wells were replaced with 
EGM-2 with 11 v/v% of FBS to examine how the additional FBS present in the cell culture media 
affected HPAEC viability. No media were replaced for the other two controls at this point. To 
remove AuNRs adsorbed only to the HPAEC surface, the I2/KI etchant was prepared.
25 After 
HPAEC was exposed to 1.0 × 10-20 moles of AuNRs/cell and EGM-2 with 11 v/v% of FBS for 3 
h, the cell media were removed and pre-warmed, 200 µL of 0.34 mM I2/KI was added to each well 
except controls without etching. Each well was incubated with I2/KI for 2 min. After I2/KI was 
aspirated, each well was washed with 200 µL of PBS and then was replaced with fresh EGM-2 
with 10 v/v% of FBS. The same procedure was repeated for control wells without etching: The 
cell media of control wells without I2/KI etching were removed. Each control well was washed 
with 200 µL of PBS and was replaced with fresh EGM-2 with 10 v/v% of FBS.  
 
3.3.10 Viability of HPAEC 
A trypan blue assay was used to determine HPAEC viability after AuNRs were removed 
from the tissue culture plate for 19 h. First, the medium of each well was removed. Then, HPAEC 
was trypsinized and centrifuged at 100xg for 4 min. After supernatant was removed, cell pellets 
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were suspended in fresh EGM-2 with 10 v/v% of FBS. Equal amounts of HPAEC suspension and 
trypan blue were mixed gently. Finally, 20 µL of HPAEC suspension-trypan blue mixture was put 
into a cell counting slide. More than 50 cells were counted manually for each sample and control 
to determine HPAEC viability. Live cells excluding trypan blue were colorless; dead cells, 
however, possessed compromised cell membranes, were stained blue. We report HPAEC viability 
through dividing the number of live cells by the number of total cells in percentage. 
 
3.3.11 Endocytic Study of AuNRs 
HPAEC was seeded at 3.0 × 105 cells/well with 1 mL of EGM-2 with 10 v/v% of FBS in 
6-well tissue culture plates. After HPAEC was seeded for 44 h, cells underwent two cycles of 
doubling time. HPAEC density increased to 1.2 × 106 cells/well. All cell culture media were 
removed and each HPAEC was exposed to 1.0 × 10-20 moles of FBS-coated, PEGylated AuNRs. 
After each well was exposed to 0.012 nM of AuNRs for 3 h, cell media were removed. Then pre-
warmed, 1 mL of 0.34 mM I2/KI was added to each well and incubated for 2 min. After I2/KI was 
aspirated, each well was washed with 1 mL of PBS. To quantify the number of PEGylated AuNRs 
taken up by HPAEC after 3 h exposure, HPAEC was trypsinized and centrifuged at 200xg for 8 
min. After supernatant was removed, a cell pellet was suspended in the mixture of 400 µL of lysis 
buffer (2 v/v% of Triton X-100 diluted in PBS) and 400 µL of H2O2 for inductively coupled plasma 
mass spectrometry (ICP-MS) to determine the gold concentration in HPAEC. Each sample of the 






3.3.12 Exocytotic Study of AuNRs 
To study time-dependent exocytosis of PEGylated AuNRs, we collected the supernatant of 
the cell culture medium at the intervals of 1, 4, 7 and 10 h after AuNRs were removed from the 
tissue culture plates. First, 1 mL of cell media was collected from each well for ICP-MS analysis. 
Then, each well was replaced with 1 mL of fresh EGM-2 with 10 v/v% of FBS. This procedure 
was repeated every three hours until the end of 10 h. All samples used for ICP-MS analysis were 
conducted in triplicate. 
 
 At the end of 19 h after AuNR etching, cell pellets were collected to determine how many 
AuNRs remained in HPAEC. Cell media were removed. Pre-warmed, 1 mL of 0.34 mM I2/KI was 
added to each well and incubated for 2 min. After I2/KI was aspirated, each well was washed with 
1 mL of PBS. HPAEC was trypsinized and centrifuged at 200xg for 8 min. After supernatant was 
removed, a cell pellet was suspended in the mixture of 400 µL of lysis buffer (2 v/v% Triton X-




UV−vis−NIR spectra were measured with a Cary 5000 UV−vis−NIR spectrophotometer 
(Agilent Technologies, USA). Zeta potential of AuNRs were determined by a Malvern Zetasizer 
Nano ZS (Malvern Panalytical, United Kingdom). Transmission electron microscopy (TEM) of 
AuNRs was collected by a JEOL 2010 LaB6 microscope (JEOL Ltd., Tokyo, Japan). Average 
lengths, widths, ARs and shape percent yields of AuNRs were determined by ImageJ software (the 
National Institutes of Health, USA). At least 300 particles were counted to determine the 
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dimensions of each batch of AuNRs. ICP-MS was used to determine the gold concentrations of 
AuNR growth solutions and endo-and exocytosis of AuNRs. A minimum of three measurements 
were taken by Thermo-Finnigan Element XR ICP-MS instrument (Thermo Fisher Scientific, 
USA).  
 
3.4 Results and Discussion 
To study whether the size-dependent endo- and exocytosis are influenced by ARs, lengths, 
widths or volumes of AuNRs. We synthesized 4 different AuNRs with three ARs, but of four 
distinct dimensions. AuNRs of AR 2.6 were made from ascorbic acid-reduce mini and standard 
AuNR syntheses. AuNRs of AR 5.2 and 9.7 were synthesized by the hydroquinone-reduced 
methods developed by Vigderman and Zubarev13 and us,26 respectively. TEM images of all AuNRs 
are shown in Figure 3.1. Their dimensions, ARs and shape percent yields are listed in Table 3.2. 
Although mini and standard AuNRs are with the same AR 2.6, but they are of different dimensions. 
The dimensions of standard AuNRs are larger than those of mini AuNRs. The former are 37.8 ± 
7.1 × 15.2 ± 2.7 nm and the latter are 24.7 ± 4.5 × 9.7 ± 2.0 nm. The average length and width of 
standard AuNRs are 1.5 time larger than those of mini AuNRs. The dimensions of AuNR AR 5.2 
and 9.7 are 74.8 ± 15.8 × 14.6 ± 2.2 nm and 80.7 ± 16.6 × 8.4 ± 0.9 nm, respectively. All AuNRs 







Figure 3.1. TEM images of AuNRs: AR a) 2.6 (mini AuNRs), b) 2.6 (standard AuNRs), c) 5.2 




Length (nm) Width 
(nm) 
Shape percent yield 
2.6 ± 0.7 
(mini AuNRs) 
655 24.7 ± 4.5 9.7 ± 2.0 98.8 (N=338) 
2.6 ± 0.6 
(standard AuNRs) 
693 37.8 ± 7.1 15.2 ± 2.7 96.4 (N=329) 
5.2 ± 1.1 940 74.8 ± 15.8 14.6 ± 2.2 95.0 (N=382) 
9.7 ± 2.3 1231 80.7 ± 16.6 8.4 ± 0.9 92.8 (N=369) 
Table 3.2. Aspect ratios (ARs), dimensions, and shape percent yield of AuNRs. The shape percent 
is defined by 
# of NRs
# of all shapes
 × 100%. N refers to the number of particles measured.  
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Figure 3.2a shows the UV-Vis spectra of these AuNRs. Their maximum longitudinal 
plasmon band wavelengths locate at 655, 693, 940 and 1231 nm. Figure 3.2b shows the AR 
distribution of the AuNRs. Despite their different maximum wavelengths, the ARs of mini and 
standard AuNRs at 655 and 693 nm are all 2.6 and their AR distributions are not considered 
significantly different at the 0.05 level (one-dimensional probability distributions were analyzed 
by two sample Kolmogorov-Smirnov Test). AuNRs with AR 2.6, 5.2 and 9.7 are not from the 
same distribution. According to Kruskal–Wallis ANOVA, the populations of these AuNRs are 
significantly different at the 0.05 level. 
 
Figure 3.2. a) UV-vis-NIR spectra of AuNRs from AR 2.6 to 9.7. The black, red, blue and green 
spectra correspond to AR 2.6 (mini AuNRs), 2.6 (standard AuNRs), 5.2, and 9.7, respectively. b) 
AR distributions of AuNRs. The black spectrum and bars correspond to mini AuNRs; red spectrum 
and bars are standard AuNRs. 
 
With this AuNR library, we have AuNRs with three different ARs (2.6, 5.2 and 9.7) and 
of the same AR, but different dimensions (mini and standard AuNRs of AR 2.6). To study how 
widths of the AuNRs will affect cellular uptake and exocytosis, we aim to compare two groups of 
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AuNRs. One is with the average widths less than 10 nm and the other is more than 10 nm. For 
mini AuNRs of AR 2.6 and 9.7, they have similar average widths (< 10 nm), but their lengths are 
very different. Mini AuNRs of AR 2.6 have average dimensions 24.7 ± 4.5 × 9.7 ± 2.0 nm, but the 
dimensions of AuNR AR 9.7 are 80.7 ± 16.6 × 8.4 ± 0.9 nm. The average length of mini AuNR 
AR 9.7 is three-time longer than that of mini AuNRs with AR 2.6. In addition, the other pair of 
AuNRs with similar average widths, but different lengths are standard AuNR AR 2.6 and AuNRs 
with AR 5.2. Their average widths are very similar: 15.2 ± 2.7 nm for standard AuNRs and 14.6 
± 2.2 nm for hydroquinone-reduced AuNRs, but the average length of AuNR AR 5.2 is roughly 
twice of that of standard AuNRs.  
 
To make AuNRs more biocompatible, we replaced CTAB bilayers with mPEG-SH. AuNR 
PEGylation was confirmed by the shifts of longitudinal LSPR peaks and the changes of 
interparticle potential from positive to negative (Figure 3.3 and Table 3.3). All longitudinal LSPR 
peaks of CTAB-coated AuNRs show blueshifts after AuNRs were PEGylated, except AuNR AR 
9.7. For example, the longitudinal LSPR peak of mini AuNR AR 2.6 shifts from 655 to 642 nm 
and that of AuNR AR 2.6 shifts from 693 to 667 nm. After PEGylation, AuNR interparticle 
potential changes from positive to slightly negative or natural. The interparticle potential of mini 
AuNR AR 2.6 is 44.8 ± 2.3 and -9.5 ± 0.9 mV for CTAB and mPEG-SH coatings, respectively. 
All PEGylated AuNRs showed aggregation when directly added to the cell culture medium. To 
improve particle stability, PEGylated AuNRs were incubated with 1 v/v% of FBS and then 
suspended in the cell culture medium. We found that the additional 1 v/v% of FBS made all 
PEGylated AuNRs stable in the cell culture medium for 21 h. Table 3.3 shows the zeta potential 
of PEGylated AuNRs in nanopure water and in the cell culture media. After FBS incubation and 
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suspension in the cell culture media, similar surface charges were observed among all PEGylated 
NRs. The zeta potential of PEGylated AuNRs are very closed to neutral (from -0.7 ± 0.8 to -6.6 ± 





Figure 3.3. UV-vis-NIR spectra of AuNRs with CTAB and mPEG-SH coatings. The red and blue 
spectra correspond to CTAB and mPEG-SH coatings, respectively. AuNRs of AR a) 2.6 (mini 































































































































































































































































































































































































































































































































































Prior to studying endo- and exocytosis of AuNRs, we investigated the viability of HPAEC 
after exposed to AuNRs to insure NR does was not lethal.  HPAEC was exposed to FBS-coated, 
PEGylated AuNRs for 3 h and then the viability was tested 19 h after 3 h AuNR incubation. Each 
HPAEC was exposed to 6.0 ×103 of FBS-coated, PEGylated AuNRs. To investigate the impacts 
of additional FBS and I2/KI etchant on viability, we prepared three more controls in additional to 
the cell culture media. One control is HPAEC cultured in the cell culture medium with additional 
FBS, another is HPAEC cultured in the cell culture medium and then treated with the I2/KI etchant, 
and the other is the HPAEC cultured in the cell culture medium with additional FBS and then 
treated with the I2/KI etchant. Figure 3.4 shows HPAEC viability in the 19
th h after incubated with 
AuNR for 3 h. All controls and HPAEC exposed to AuNRs show average viability higher than 
82%. Interesting, the lowest viability was HPAEC cultured with the cell culture medium along 
with additional FBS for just 3h. In most cell culture conditions, FBS contributes to 5–10 v/v% 
of the cell culture medium. With the additional 1 v/v% of FBS used for NR stabilization, there was 
11 v/v% of FBS present in the cell culture medium. It is possible that the additional FBS 
contributes to decreases in HPAEC viability. The same result shows in the HPAEC treated with 
the cell culture medium containing additional FBS and was etched. Compared to HPAEC treated 
by the I2/KI etchant alone, the HPAEC treated with additional FBS shows lower viability. It has 
been shown that deficient or excessive micronutrients affect cell viability and genomic stability. 
Excess vitamin B7, C and E increase DNA damage related to oxidative stress.27 After HPAEC was 
exposed to FBS-coated, PEGylated AuNRs for 3 h, the highest to lowest viability is from the 






Figure 3.4. Viability of HPAEC in the 19th h after exposed to FBS-coated, PEGylated AuNRs for 
3 h. The yellow, blue, pink, olive, cyan, orange, green and purple bars correspond to control 
(HPAEC cultured in the cell culture media with 10 v/v% FBS), control with additional FBS 
(HPAEC treated with the culture media with 11 v/v% FBS), control received I2/KI etching 
(HPAEC cultured in the cell culture media with 10 v/v% FBS and etched), control with additional 
FBS received I2/KI etching (HPAEC treated with the cell media with 11 v/v% FBS and etched), 
HPAEC exposed to mini AuNR AR 2.6, standard AuNR AR 2.6, AuNR AR 5.2 and AuNR AR 
9.7, respectively. All data were reported as mean ± standard deviation and the standard deviation 
resulted from three individual cell culture wells.  
 
To quantify how many AuNRs were taken up by HPAEC after 3 h incubation, we removed 
the cell media containing PEGylated AuNRs. Then we used I2/KI to etch any AuNRs adsorbed to 
the cell surface to quantify the amount of AuNRs endocytosed. Figure 3.5a shows the number of 
AuNRs taken up by HPAEC on a per cell basis. The cellular uptake of PEGylated mini AuNRs of 
AR 2.6 is the most. This result is consistent with many studies, which showed AuNRs of the 
smallest AR were taken up the most by mouse endothelial cells (C166),23 mouse fibroblast STO 


















cells, cervical cancer cells (HeLa cells), human glioblastoma cells (SNB-19).19 AuNRs of AR 9.7 
and AR 5.2 were the second and the third abundance in HPAEC. Standard AuNRs of AR 2.6, 
however, were the least to be taken up by HPAEC. These results show that cellular uptake is not 
dominated by NR ARs since mini and standard AuNRs of the same AR differ in their endocytosed 
amounts. We found that the cellular uptake of AuNRs is less dependent upon the ARs, lengths and 
volumes of NRs (Figure 3.6). There is a low correlation (R2 = 0.11215) between the endocytosis 
of AuNRs and rod ARs. The low correlations (R2 < 0.18) also occurs between the cellular uptake 
of AuNRs and rod lengths and between NR endocytosis and the volumes of rods. We, however, 
found that the cellular uptake of AuNRs depends more on the widths of AuNRs. There is a negative 
correlation (R2 = 0.6501) between the cellular uptake of rods and rod widths. Although their AR 
was the highest, AuNRs with an average width less than 10 nm were endocytosed more than those 
with average widths larger than 10 nm. This shows that the cellular uptake of AuNRs depends 
more on the widths rather than the lengths, ARs and volumes of rods. 
 
Our results show that the size dependent cellular uptake of AuNRs is more dependent on 
the widths than the ARs, lengths and volumes of AuNRs. Both mini AuNRs of AR 2.6 and AuNRs 
with AR 9.7 have the average widths less than 10 nm, 9.7 ± 2.0 and 8.4 ± 0.9 nm, respectively. 
Compared to standard AuNRs of AR 2.6 and AuNR AR 5.2 with average widths ~15 nm, the 
smaller widths (< 10 nm) made the cellular entry of both mini AuNRs of AR 2.6 and AuNR AR 
9.7 easier. This tip-entry uptake of anisotropic nanomaterials has been shown in experimental and 
computational studies.28-31 The rotation of AuNRs regulates the competition between ligand-
receptor binding and membrane deformation.29 However, the percentage of this entry still requires 
more studies. Figure 3.5b shows the number of Au taken up by HPAEC on a per well basis after 3 
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h incubation. From the largest to the least amounts of Au taken up by HPAEC, the order is AuNR 
AR 5.2, AR 9.7, standard AuNRs of AR 2.6 and mini AuNRs of AR 2.6. This uptake trend is 
different from the uptake pattern accounting for the number of AuNRs/cell. This could be 
explained by that although each HPAEC did not take up more AuNRs with AR 5.2, the volume of 




Figure 3.5. Endocytic studies of HPAEC after exposed to FBS-coated, PEGylated AuNRs. 
Cellular uptake was reported by a) the number of AuNRs per cell and b) the amount of gold per 
cell culture well. Each well has 1.2 × 106 cells. Orange and green bars correspond to endocytoses 
after 3 h AuNR incubation, and in the 19th h post AuNR incubation, respectively. All data were 
reported as mean ± standard deviation and the standard deviation resulted from three individual 










Figure 3.6. Correlations between the endocytosis of FBS-coated, PEGylated AuNRs and different 
parameters related to rod sizes. Plots of the endocytosis of AuNRs versus a) AR, b) length, c) 
volume and d) width of AuNRs. R2 = 0.11215, 0.00829, 0.17969, and 0.65015, respectively. Black 
lines show linear regression.  
 
After HPAEC was exposed to FBS-coated, PEGylated AuNRs for 3 h, we monitored the 
exocytosis of AuNRs from the 1st h until the 10th h. We reported the exocytosis of AuNRs by a 
fraction, which is defined as the number of exocytotic AuNRs divided by the number of 
endocytic AuNRs in percentage. Figure 3.7a shows that at the 1st h of exocytosis, HPAEC exposed 
to AuNR AR 5.2 removed 43 ± 39% of rods. Most AuNR AR 9.7 remained in HPAEC. The 
76 
 
exocytotic fraction is only 15 ± 6%. The exocytotic fractions of mini and standard AuNRs of AR 
2.6 are 23 ± 4 and 31 ± 4%, respectively. At the end of 10 h after AuNR exposure, more than 75% 
of AuNR were removed from HPAEC. We found that there were more AuNRs present in the 
HPAEC exposed to mini AuNRs of AR 2.6 (Figure 3.5a) at the end of 19 h after 3h NR exposure; 
in contrast, HPAEC exposed to AuNR AR 5.2 shows the least amount of AuNRs remained. This 
trend is very similar to the pattern of AuNR uptake. It is possible that it takes longer to remove 
mini AuNRs of AR 2.6 due to their initial larger uptake amount. We also report AuNR exocytosis 
by the amount of Au remained in each well shown in Figure 3.7b. 
 
Figure 3.7. Kinetics of exocytosis. Exocytosis was reported as a) the fraction of AuNRs removed 
with respect to the initial uptake amount and b) the amount of remaining gold per cell culture well. 
Each well has 1.2 × 106 cells. The exocytosis was measured after 1, 4, 7 and 10 h post AuNR 
incubation. All data were reported as mean ± standard deviation and the standard deviation resulted 







We used four different, seed-mediated syntheses to synthesize four types of AuNRs to 
investigate size-dependent endo- and exocytosis. To understand whether the size-dependent 
cellular uptake and removal are dominated by the ARs, lengths, widths or volume of AuNRs, we 
prepared four types of PEGylated AuNRs with four distinct dimensions, but with only three ARs 
(2.6, 5.2 and 9.7). We found that AuNRs with the same AR 2.6, but of different dimensions were 
taken up by HPAEC with very different amounts. The dimensions of mini AuNRs were smaller 
than those of standard AuNRs. The cellular uptake of mini AuNRs was twofold more than that of 
standard AuNRs. We observed that AuNRs with average widths less than 10 nm were endocytosed 
more than those with average widths larger than 10 nm. This observation shows that AuNR cellular 
uptake is more dependent on the width of rods than the ARs, lengths and volumes.  In additional 
to endocytosis, we investigated exocytotic rates within 10 h. Our results show that more than 75% 
of AuNR were removed from HPAEC at the end of 10 h after AuNR exposure. 
  
3.6 Future Work 
We planned to repeat this experiment to confirm the size-dependent effects of AuNRs on 
endo- and exocytosis. In additional to cellular uptake and removal of NRs, we would like to 
observe how HPAEC transports AuNRs by sectional TEM images to elucidate the intracellular 
transportation of rods and correlate the transportation pathways of slowly-and fast-excreted 
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CHAPTER 4: IMPACT OF GOLD NANOPARTICLE AEROSOLS ON HUMAN SMALL 
AIRWAY EPITHELIUM DIFFERENTIATION 
 
4.1 Abstract 
Although concerns of fine particulate air pollution arise, our understanding of the health 
implications of inhaled nanoparticle aerosols is still incomplete due to lack of real-time 
measurement of disease progression at cellular and molecular levels. To mimic the complex 
composition, physiological function and cell diversity of human lungs, we built a 3-dimentional 
human lung model cultured at an air-liquid interface to represent a pulmonary blood-air barrier. 
We aim to understand the interaction between human lungs and nanoparticle aerosols through 
investigating how the surface chemistry and doses of gold nanospheres influence human small 
airway epithelium differentiation. First, negatively charged, citrate-capped and positively charged, 
triple-wrapped poly(allylamine hydrochloride) gold nanospheres were stabilized in a mixture of 
two cell culture growth media by sequential protein incubation protocols. To mimic human 
inhalation, gold nanosphere aerosols were delivered to the cocultures of primary human small 
airway epithelial and pulmonary artery endothelial cells through nebulization. We quantified the 
numbers of gold nanospheres from an ultrasonic nebulizer to match human realistic ambient and 
worst-case exposure with tissue dose fluxes 5.6 × 106 and 4.6 × 108 NSs/cm2, respectively. All 
human lung cocultures exposed to the ambient and worst-case exposure show successful 
epithelium differentiation of goblet, ciliated and club cells. Finally, we monitored the long-term 
progression of tumor necrosis factor, transforming growth factor beta, and interleukin 6 present in 
the cocultures to show changes of inflammatory responses from the 1st day of gold nanosphere 
aerosol exposure to the end of 21st day until epithelium differentiation. Although all human lung 
models successfully differentiated, we observed more than three-fold increases in interleukin 6 on 
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the 21st day, showing the possibility of chronic inflammation in the cocultures exposed to gold 
nanosphere aerosols regardless of nanoparticle surface chemistry and doses. 
 
4.2 Introduction 
The primary organ of the respiratory system is the lungs, where gas exchanges of oxygen 
and carbon dioxide happen. Before arriving alveoli as the destination for gas exchanges, air first 
passes through noses or mouths, tracheas and bronchioles. As urbanization and industrialization 
expand, concerns about potential human health effects resulted from air pollution, especial fine 
particles, arise. According to the United States Environmental Protection Agency (EPA), fine 
particulate matter (PM2.5) less than or equal to 2.5 µm in aerodynamic diameter travels more 
deeply into small airways and the alveoli than larger particles (PM10).
1 Studies show that short-
term exposure to PM2.5 increases the risk for hospital admission for respiratory diseases and long-
term exposure has been associated with increased rates of chronic bronchitis, reduced lung 
function and increased mortality from lung cancer and heart disease.1-2 In additional to 
environmental, occupational and biomedical exposure, as engineered, nanomaterial consumer 
products emerge rapidly, more attention has been drawn to understand the health implications 
of inhaled nanoparticle (NP) aerosols.  
 
Although NP-lung interaction has been studied extensively for decades, using an in-vitro 
model to predict and represent in-vivo physiological responses remains a challenge. To mimic the 
physiological complexity of the lung, multiple cell types should be incorporated in the in-vitro 
model. Luminal surfaces of the in-vivo airway are lined with a pseudostratified epithelium, which 
contains ciliated, goblet, club and basal cells.3 The relative distribution and the abundance of each 
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cell type vary in airway regions and each cell possesses different cell functions. Ciliated cells have 
tiny hair-like structures, propelling mucus up and out of the respiratory tract.4 Goblet cells secrete 
high molecular weight mucin glycoproteins to maintain airway moisture and trap pathogens or 
particles.3 Club cells are non-ciliated, non-mucous secretory cells with the primary secretory 
product uteroglobin.5 Basal cells provide the foundation for ciliated and goblet cells attached to 
basal laminae.3.6 Basal cells also contribute to tissue regeneration and innate.6 In addition to 
mimicking diverse cell types of lungs, an air-liquid interface (ALI) instead of submerged cultures, 
should be created to better represent the air exchange function of lungs. Finally, to resemble human 
inhalation, a lung model should be exposed to a mixture of solid particles and gases, not NP 
solutions. 
 
Despite challenges of mimicking in-vivo human lung models, several pioneer studies 
revealed how human lung cocultures respond to NP aerosols in terms of pro-inflammatory and 
oxidative stress markers and membrane integrity at the ALI. Brandenberger et al. found that no 
significant increases of pro-inflammatory and oxidative stress markers presented in a triple cell 
coculture model exposed to aerosols of 15-nm, citrate-capped gold nanospheres (AuNSs).7 Their 
cocultures of human lung epithelial carcinoma cells (A549), human blood monocyte derived 
macrophages (MDM) and monocyte-derived dendritic cells (MDDC) show no significant changes 
of tumor necrosis factor (TNF-α), interleukin 8 (IL-8), inducible nitric oxide synthase 
(iNOS), heme oxygenase-1 (HO-1) and superoxide dismutase 2 (SOD2). Similar results, no TNF-
α or IL-8 increases were observed, when the same cocultures exposed to 20 nm, citrate-coated 
silver NSs and polyvinyl alcohol and polyallylamine-capped AuNSs shown by Herzog et al.8 and 
Durantie et al.,9 respectively. Both studies show cocultures maintained membrane integrity after 
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NS aerosol exposure.  In contrast to those three studies, different cocultures of immortalized 
human bronchial epithelial cells (BEAS-2B) and differentiated THP-1 macrophages were exposed 
to fly ash, resulting in increases of IL-8 and HO-1.10 Although these results seem be to 
contradictive to the previous ones, this discrepancy could arise from inherent differences in 
cocultures and aerosols between studies.  
 
Other studies, however, not incorporated either cocultures, the ALI, or NP aerosols have 
offered insights into the differences in cytotoxicity and inflammatory responses between mono-
and cocultures and between the ALI and submerged systems. Kasper et al. showed that compared 
to monocultures of human lung epithelial papillary adenocarcinoma (H441) and 
malignant endothelial cell line (ISO-HAS-1), higher viability, membrane integrity and 
transepithelial electrical resistance were observed when cocultures were exposed to the same dose 
of amorphous silica NPs.11 Triple cell cocultures of A549, MDM and MDDC after exposed to 
diesel exhaust particles, titanium dioxide and single-walled carbon nanotubes show higher total 
antioxidant capacity and IL-8, but lower TNF-α concentrations than monocultures.12 Different 
physiological responses were also observed between the ALI and submerged cultures. Normal 
human bronchial epithelial (NHBE) and BEAS-2B cultured at the ALI show diminished 
concentrations in IL-8, IL-6, HO-1 and cyclooxygenase 2 (COX-2) compared to their submerged 
counterparts exposed to the same ambient air pollution.13 In contrast to the previous study, another 
study shows higher levels of IL-8, IL-6, and granulocyte-macrophage colony-stimulating 
factor (GM-CSF) present in A549 at the ALI than the submerged culture exposed to airborne 




To understand how human lungs interact with NP aerosols, we built a 3-dimentional (3D) 
human lung model of diverse cell types cultured at the ALI.  Through our NP library, we 
investigated the impacts of AuNS surface chemistry and tissue doses on human small airway 
epithelium differentiation. Before aerosol delivery of NPs, negatively charged, citrate-capped and 
positively charged, triple-wrapped poly(allylamine hydrochloride) (PAH) NSs were stabilized in 
a mixture of two cell culture growth media by sequential protein incubation protocols. NS aerosols 
were delivered to the cocultures of primary human small airway epithelial and pulmonary artery 
endothelial cells through nebulization to mimic human inhalation. We quantified the numbers of 
AuNSs from an ultrasonic nebulizer to match human realistic ambient and worst-case exposure 
with tissue dose fluxes 5.6 × 106 and 4.6 × 108 NSs/cm2, respectively. All 3D human lung models 
exposed to the ambient and worst-case exposure successfully differentiated to goblet, ciliated and 
club cells. To investigate the long-term physiological changes of our lung models, we report TNF-
α, transforming growth factor beta (TGF-β), and IL-6 to show inflammatory responses from the 
1st day of AuNS aerosol exposure to the end of 21st day until the epithelium differentiated. We 
found at least three-fold increases of IL-6 occurred in the cocultures exposed to AuNS aerosols 
despite different surface chemistry and doses, indicating chronic inflammation produced at the 
sites although all human lung models successfully differentiated. 
  
4.3 Experimental Section 
4.3.1 Materials 
AuNS Synthesis. Chloroauric acid (HAuCl4 • 3H2O, ≥ 99.9%), sodium citrate tribasic 
dihydrate (Na3Ct • 2H2O, ≥ 99.0%) hydroquinone (≥ 99%), poly(allylamine hydrochloride) (PAH, 
average Mw∼17,500),  poly(acrylic acid and sodium salt) solution (PAA, average Mw∼15,000, 
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35 wt% in water) were purchased from Sigma-Aldrich. Sodium chloride (ACS grade) was acquired 
from EMD Chemicals. All chemicals were used as received without further purification.  
 
Cell Culture. Primary human small airway epithelial cells (SAEC), small airway epithelial 
cell basal medium (SABM™ medium), small airway epithelial cell growth medium (SAGM™) 
SingleQuots™ kit, primary human pulmonary artery endothelial cells (HPAEC), endothelial cell 
basal medium-2 (EBMTM-2), endothelial cell growth medium-2 (EGMTM-2) 
SingleQuotsTM supplements, Trypsin/EDTA solution (0.025%) and phosphate buffered saline 
(PBS, without calcium and magnesium) were purchased from Lonza. Fetal bovine serum (FBS, 
sterile-filtered) was purchased from Millipore Sigma. Transwell® (6.5-mm Transwell® with 0.4-
µm Pore Polyester Membrane Insert) and HEPES (1M) were purchased from Corning. Triton X-
100 (laboratory grade), bovine serum albumin-fatty acid free (BSA-FAF, heat shock fraction, 
lyophilized powder, essentially fatty acid free, ≥98%), collagen-I (rat tail, sterile-filtered,  
> 95%), bovine serum albumin (heat shock fraction, pH 7, ≥98%) and fibronectin (bovine plasma, 
in 150 mM NaCl, 20 mM sodium phosphate buffer, pH 7.3) were purchased from Sigma-Aldrich. 
PneumaCult™ ALI basal medium, PneumaCult™-ALI 10X supplement, PneumaCult™-ALI 
maintenance supplement, heparin solution (0.2%) and hydrocortisone stock solution were obtained 
from STEMCELL Technologies. Primary antibodies: Acetyl-α-Tubulin (Lys40) (D20G3) XP® 
rabbit mAb (1:200 dilution) was obtained from Cell Signaling Technology; rat anti-human 
uteroglobin/SCGB1A1 antibody (1:50 dilution, clone 394324) was obtained from R&D Systems; 
mouse anti-MUC5AC antibody (45M1) (1:50 dilution) was obtained from Novus Biologicals. 
Secondary antibodies: Goat anti-rabbit IgG Cy3 (1:100 dilution) was obtained from Abcam. Goat 
anti-rat IgG (H+L) cross-adsorbed secondary antibody, Alexa Fluor 647 (1:50 dilution) and goat 
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anti-mouse IgG2b cross-adsorbed secondary antibody, Alexa Fluor 488 (1:100 dilution) were 
purchased from Invitrogen. ProLong™ gold antifade and ProLong™ glass antifade mountants 
were purchased from Invitrogen. 4',6-diamidino-2-phenylindole (DAPI, 1:1000 dilution) was 
purchased from Sigma. 
 
4.3.2 Synthesis of AuNSs 
Preparation of a Gold Seed Solution. AuNSs were synthesized by a seed-mediated growth 
method developed by Perrault and Chan.15 A gold seed solution was prepared by citrate reduction. 
First, a gold solution containing 0.12 L of nanopure water and 1.2 mL of 1.0 w/v% HAuCl4 • 3H2O 
was prepared. Next, the solution was stirred and brought to a rolling boil. Once the solution was 
boiling, 3.6 mL of 1.0 wt% sodium citrate was added. The temperature of the solution was reduced 
to prevent further boiling, but the solution was continuously heated for an additional 10 min. After 
10 min, the heat was turned off and the solution was cooled naturally on a hot plate to room 
temperature (~1 h). To purify the Au seeds, the solution was centrifuged at 11,000xg for 20 min. 
The supernatant was removed, and the pellet was dispersed in nanopure water. 
 
Synthesis of AuNSs. To make hydroquinone-reduced AuNSs with diameters of ~50 nm, 
aqueous stock solutions of 1.0 w/v% HAuCl4 • 3H2O and 0.030 M hydroquinone were freshly 
prepared. First, 1.0 w/v% HAuCl4 • 3H2O was centrifuged at 18,000xg for 60 min to remove any 
aggregates present in the solution. The supernatant was collected for further use and the pellet was 
discarded. Next, a growth solution containing 10 mL of the purified 1.0 w/v% HAuCl4 • 3H2O and 
0.95 L of nanopure water was prepared and the solution was stirred rapidly at room temperature. 
To synthesize ~50-nm AuNSs, 36 mL of 1.7 nM of the gold seed solution, 2.2 mL of 1.0 wt% 
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sodium citrate and 10 mL of 0.030 M of hydroquinone were added in sequence to the growth 
solution and the solution was kept stirred for ~40 min. After 40 min, the solution was centrifuged 
at 5,000 xg for 20 min. The supernatant was removed, and the pellet was dispersed in nanopure 
water.  
 
4.3.3 Polyelectrolyte Coatings of AuNSs 
Positively charged, triple-coated (PAH-PAA-PAH) AuNSs were prepared by our previous 
method with the following modifications.16-17 To deposit the first layer of PAH onto citrate-capped 
~50-nm AuNSs, a mixed solution of 0.010 M NaCl and 10 mg/mL of PAH (1:2 in volume) was 
prepared. For a 1 mL scale polyelectrolyte wrapping, 0.30 mL of the previously made, mixed NaCl 
and PAH solution was added to 0.90 mL of 0.10 nM AuNSs and the solution was gently shaken 
for 2 h. After 2 h incubation, the solution was centrifuged at 4,900xg for 20 min. The supernatant 
was removed, and the pellet was dispersed in 0.81 mL of nanopure water. Then, a mixed solution 
of 0.010 M NaCl and 10 mg/mL of PAA (1:2 in volume) was prepared. The deposition of PAA 
was initiated by adding 0.54 mL of the previously made, mixed NaCl and PAA solution to 0.81 
mL of AuNSs. The solution was gently shaken for 2 h. After 2 h, the solution was centrifuged at 
4,900xg for 12 min. The supernatant was removed, the pellet was dispersed in 0.90 mL of nanopure 
water. The procedure was repeated to prepare the final PAH layer: 0.30 mL of the mixed 0.010 M 
NaCl and 10 mg/mL of PAH solution (1:2 in volume) was added to 0.90 mL of AuNSs and the 
solution was gently shaken for 2 h. After 2 h incubation, the solution was centrifuged twice at 
4,900xg for 12 min. The supernatant was removed, the pellet was dispersed in nanopure water. All 
particles were passed through sterile, 0.22-µm, surfactant-free, cellulose acetate syringe filters 
prior to cellular studies. 
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4.3.4 Cell Culture  
Monoculture. SAEC from a non-smoking, 47-year-old, Hispanic female donor was 
cultured in serum-free, small airway epithelial cell growth medium (SAGM). To formulate SAGM, 
each supplement of SAGMTM SingleQuotsTM kit was added to SABM™ medium. The seeding 
efficiency of this batch of SAEC was 97% with doubling time of 20 h determined by Lonza, Inc. 
HPAEC was kindly provided by Prof. Deborah Leckband and was cultured in endothelial cell 
growth medium-2 (EGM-2) supplemented with 10 v/v% of FBS. To formulate EGM-2, EGMTM-
2 SingleQuotsTM was added to EBMTM-2. SAEC at passage 2 and HPAEC at passage 8-9 were 
used for all experiments. Both SAEC and HPAEC were cultured in a 37
°C humidified incubator 
with 5% CO2 according to the manufacturer’s protocol. 
 
4.3.5 Stability of AuNSs in Cell Culture Medium 
A mixed cell culture medium composed of EGM-2 supplemented with 2% FBS and 
PneumaCult™-ALI maintenance medium (1:1 in volume) was used to culture SAEC and HPAEC 
together. PneumaCult™-ALI maintenance medium was formulated by adding PneumaCult™-ALI 
10X supplement, PneumaCult™-ALI maintenance supplement, heparin solution and 
hydrocortisone stock solution to PneumaCult™ ALI basal medium according to the manufacture’s 
protocol. To make AuNSs of different surface chemistry stable in this mixed medium, two 
different protein incubation protocols were required. To stabilize citrate-capped AuNSs, AuNSs 
were added to 1 v/v% of BSA-FAF (1.2 w/v% in HEPES buffer) at room temperature. After 40 
min incubation, 1 v/v% of FBS was introduced to the solution and followed by another 40 min 
incubation. Finally, the mixed medium was added to the incubated AuNSs. For triple-wrapped 
PAH AuNSs, the same procedure described above was used; however, the amounts of BSA-FAF 
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and FBS were increased to 10 and 5 v/v%, respectively. These stabilization protocols made citrate-
capped and triple-wrapped PAH AuNSs stable in the mixed medium up to three days. 1 v/v% of 
BSA-FAF means when AuNSs mixed with the mixed medium, the additional concentration of 
BSA-FAF was 1 v/v% (not including the BSA-FAF already existed in the medium); similarly, 
additional 1 v/v% of FBS was added to the mixed medium to stabilize citrate-capped AuNSs.  
 
4.3.6 Quantification of Aerosol Delivery of AuNSs  
An ultrasonic nebulizer (ClinicalGuard Ultrasonic Portable Nebulizer HL100, Clinical 
Guard, Inc.) was used to deliver AuNS aerosols to our 3D lung model. To quantify the amount of 
AuNSs delivered by this nebulizer, we constructed a calibration curve for each type of AuNSs. 
Each calibration curve was established by six different concentrations of AuNSs. First, AuNSs 
were incubated with BSA-FAF, FBS and the mixed media according to the protein incubation 
protocols listed in Section 4.3.5. Then, each solution was warmed up to 37°C for 5 min prior to 
nebulization. A 6" × 6" × 6"chamber was used to confine nebulized AuNSs. Inside the chamber, a 
transmission electron microscopy (TEM) grid was set on a piece of parafilm to collect AuNS 
deposition. Then, 800 µL of the AuNS solution was transferred to the medicinal chamber of the 
nebulizer and was nebulized for 2 min. After 2 min, we allowed AuNS aerosols to settle down in 
the chamber for 15 min. After 15 min, the TEM grid was removed from the chamber and dried in 
an ambient condition. Finally, we counted the number of AuNSs in a fixed TEM area to figure out 






4.3.7 Cocultures of SAEC and HPAEC 
Fibronectin Coating of a Transwell® Insert. Before HPAEC was seeded on the basal side 
of a Transwell® porous membrane, 20 μg/mL of fibronectin diluted with PBS was prepared to 
coat the basal side of the membrane. First, a Transwell® insert was inverted. Then, 50 μL of 20 
μg/mL fibronectin was added dropwise to the basal side of the Transwell® membrane and the 
membrane was incubated in the 37 °C incubator for 30 min (Figure 4.1). After 30 min excess 
fibronectin was removed by aspiration.  
 
Preparation of HPAEC. After EGM-2 with 10% FBS was removed from a cell culture 
flask, 5 mL of PBS was added to the flask and was aspirated. Then, 2 mL of trypsin was added to 
the flask followed by 5 min incubation at 37°C. After incubation 2 mL of EGM-2 with 10% FBS 
was added to the flask. To estimate the number of HPAEC in the flask, 20 μL of cell suspension 
was taken out and a hemocytometer was used for a cell count. The total number of cells were 
estimated by averaging the number of cells at four corners of the hemocytometer. Each corner has 
the number of cells × 104/mL. Then the number of cells in the flask was calculated by a dilution 
factor. HPAEC was centrifugated 200xg for 5 min. The supernatant was removed, and a cell pellet 
was resuspended in EGM-2 with 10% FBS to prepare HPAEC suspension.  
 
HPAEC Seeding. After excess fibronectin was removed, each Transwell® membrane was 
seeded with 50 μL of the HPAEC suspension, making 20,000 cells per well. Transwell® inserts 
were put back to the incubator for 30 min to allow HPAEC to attach on the membrane. For the 
following steps, work with one Transwell® insert at a time: After excess media on the Transwell® 
membrane were removed by aspiration, each Transwell® was inverted and was put back to a 
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Transwell® plate. Then, 500 μL of EGM-2 with 10% of FBS was added to each basal chamber of 
the Transwell® plate. After all Transwell® inserts were put back to the plate, excess media were 
removed by aspiration if the top side of the Transwell® membrane was not dry. After HPAEC was 
cultured overnight, SAEC was seeded on the next day on the apical side of the Transwell® inserts.  
 
 
Figure 4.1. Schematic representations of coating a Transwell® insert with fibronectin and seeding 
HPAEC.   
 
Collagen-I Coating of a Transwell® Insert. Before SAEC was seeded on the apical side of 
a Transwell® porous membrane, 30 μg/mL of rat tail collagen-I diluted in PBS was prepared. First, 
100 μL of 30 μg/mL rat tail collagen-I was added dropwise to the apical side of each Transwell® 
membrane and Transwell® inserts were incubated in the 37°C incubator for 30 min (Figure 4.2). 
After 30 min excess collagen-I was removed by aspiration.  
 
Preparation of SAEC. Before trypsinization of SAEC, 2 mL of SAGM with 10% of FBS 
was prepared. After SAGM was removed from a cell culture flask, 5 mL of PBS was added to the 
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flask and was aspirated. Then, 2 mL of trypsin was added to the flask followed by 5 min incubation 
in the 37°C incubator. After incubation, 2 mL of SAGM with 10% of FBS was added to the flask. 
To estimate the number of SAEC in the flask, 20 μL of cell suspension was taken out for a cell 
count. SAEC was centrifugated 220xg for 5 min. The supernatant was removed, and a cell pellet 
was resuspended in SAGM to prepare 60,000 cells/100 μL for each Transwell® insert. 
 
SAEC Seeding. After excess collagen-I was removed, each apical side of Transwell® 
inserts was seeded with 100 μL of SAEC, making 60,000 cells per Transwell® insert. Transwell® 
inserts were put back to the 37 °C incubator for 6 h to allow SAECs to attach on Transwell® 
membranes.  
 
Medium Replacement. After 6 h, a mixed cell culture medium of EGM-2 supplemented 
with 2% of FBS and SAGM (1:1 in volume) was prepared. After old media at the basal chambers 
of the Transwell® plates were removed, 500 μL of PBS was added to each basal chamber and then 
the PBS was removed. Then, 500 μL of the mixed cell culture medium of EGM-2 with 2% of FBS 
and SAGM was added to each basal chamber. To avoid unintentionally transferring HPAEC to the 
apical chamber, new Pasteur and serological pipettes were used to replace apical chamber cell 






Figure 4.2. Schematic representations of collagen-I coating of a Transwell® insert, seeding of 
SAEC and medium replacement before an airlift process. 
 
ALI Culture. An airlift process was performed according to the following procedure (Figure 
4.3). After old media at the basal chamber of the Transwell® plate were removed, 500 μL of PBS 
was added to each basal chamber and the PBS was removed. Then, 500 μL of the mixed cell culture 
media composed of EGM-2 with 2% of FBS and PneumaCult™ ALI maintenance medium (1:1 
in volume) was added to each basal chamber. To avoid unintentionally transferring HPAEC to the 
apical chambers, new Pasteur and serological pipettes were used for replacing apical chamber 
media. First, old media at the apical chambers were removed. Then, 100 μL of PBS was added to 




Figure 4.3. Schematic representations of the airlift process. 
 
4.3.8 Aerosol Exposure  
Before our 3D lung model was exposed to AuNS aerosols, AuNS solutions were prepared 
by incubating AuNSs with BSA-FAF, FBS and the mixed cell culture media (EGM-2 with 2% of 
FBS and PneumaCult™ ALI maintenance medium; 1:1 in volume) based on the protein incubation 
protocols listed in Section 4.3.5. To examine how SAEC differentiation was affected by AuNS 
surface chemistry and doses, we mimicked six different scenarios, including four samples exposed 
to AuNSs and two additional controls without AuNS exposure. For three control cocultures, they 
were not exposed to any AuNSs. One received no aerosols and the other two were exposed to the 
aerosols of the mixed cell culture medium with additional BSA-FAF and FBS. The controls 
exposed to the mixed cell culture medium aerosols was treated by different amounts of proteins: 
One was exposed to 1 v/v% of BSA-FAF and 1 v/v% of FBS and the other was treated by 10 v/v% 
of BSA-FAF and 5 v/v% of FBS corresponding to the protein incubation protocols for citrate-
capped and triple-wrapped PAH AuNSs, respectively. For cocultures exposed to AuNSs, there 
were two target tissue dose fluxes to mimic human inhalation of realistic ambient and worst-case 
exposure, which correspond to 2 and 300 NPs/cell/h, respectively.18 To deliver an 8 h dose flux 
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for 2 min nebulization, the AuNS concentrations for ambient and worst-case exposure to citrate-
capped AuNSs were 0.0010 and 0.40 nM, respectively.  Those for ambient and worst-case 
exposure to triple-wrapped PAH AuNSs were 0.0035 nM and 0.43 nM, respectively. The 
concentrations were determined by the calibration curves established in Section 4.3.6. To mimic 
human inhalation, all solutions were warmed up to 37°C prior to nebulization. Then, three 
Transwell® inserts of the same exposure scenario were transferred to a new Transwell® plate 
filled with fresh mixed cell culture media to avoid cross-contamination between different aerosols 
(Figure 4.4). After the Transwell® plate was set inside the chamber, 800 µL of the AuNS solution 
or the mixed cell culture medium with additional BSA-FAF and FBS was transferred to the 
medicinal chamber and was nebulized for 2 min. After 2 min, we allowed AuNS aerosols to settle 
down in the chamber for 15 min. Then, three Transwell® inserts were put back to their original 
plate and incubated at 37°C for 8 h. We used different medicinal chambers of the nebulizer for 
citrate-capped and triple-wrapped PAH AuNSs to avoid cross-contamination between different 
aerosols. 
 




4.3.9 ALI Maintenance  
After the 3D lung model was exposed to AuNSs and mixed cell culture media with 
additional BSA-FAF and FBS for 8 h, 150 μL of basal chamber media was collected for protein 
analysis (AssayGate, Inc., USA).  Then, basal chamber media were removed, and each basal 
chamber was washed by 500 μL of PBS. After the PBS was removed, each basal chamber was 
replaced by 500 μL of fresh, mixed cell culture media (EGM-2 with 2% of FBS and PneumaCult™ 
ALI maintenance medium; 1:1 in volume). To avoid transferring SAEC between different 
treatments, we changed Pasteur pipettes for each exposure scenario when the apical chamber 
media were aspirated. Finally, 100 μL of PBS was added to each apical chamber to wash SAEC 
and the apical chamber was left dry.  
 
To quantify changes of inflammatory responses in our lung model, 150 μL of the basal 
chamber media was collected on the 3rd, 9th, 15th and 21st day after aerosol exposure. During the 
following 3 weeks, basal chamber media were removed, and each basal chamber was washed by 
500 μL of PBS and replaced by 500 μL of fresh, mixed cell culture media (EGM-2 with 2% of 
FBS and PneumaCult™ ALI maintenance medium; 1:1 in volume) every 3 days. Then, each apical 




Figure 4.5. Schematic representations of ALI medium replacement until SAEC differentiation. 
 
4.3.10 Immunofluorescence Staining 
           Fixation. On the 24th day after the ALI was created, cell culture media from the basal 
chamber were removed by aspiration and the basal and apical chambers were wash with 1 mL and 
500 µL of PBS, respectively (Figure 4.6). After PBS was removed, 1 mL and 500 µL of fixation 
buffer (4% paraformaldehyde in PBS) were added to the basal and apical chambers, respectively. 
The Transwell® inserts were incubated at room temperature for 15 min with slow rocking. After 
15 min, the fixation buffer was removed, and the basal and apical chambers were wash with 1 mL 
and 500 µL of PBS, respectively. Transwell® inserts were washed with PBS three times on the 
rocking platform. For each wash, the old PBS was removed, fresh PBS was added to the basal and 
apical chambers and Transwell® inserts were set on the rocking platform for 5 min.  
 
           Permeabilization. The PBS of the basal and apical chambers was removed. To check 
differentiation of SACE, HPAEC on the basal side of the Transwell® membrane was wiped out 
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with Kimwipes. Then, 1 mL and 500 µL of permeabilization buffer (0.1 v/v% Triton X-100 in 
PBS) were added to the basal and apical chambers, respectively. The Transwell® inserts were 
incubated at room temperature for 5 min with slow rocking. After 5 min, the permeabilization 
buffer was removed and the basal and apical chambers were wash with 1 mL and 500 µL of PBS, 
respectively. The Transwell® inserts were washed with PBS three times on the rocking platform. 
For each wash, the old PBS was removed, fresh PBS was added to the basal and apical chambers 
and the Transwell® inserts were set on the rocking platform for 3 min. 
 
           Blocking Non-Specific Antibody Binding. After the PBS of the basal and apical chambers 
was removed, 1 mL and 500 µL of blocking buffer (1 w/v% of BSA in PBS) were added to the 
basal and apical chambers, respectively. Then, the Transwell® plate was wrapped with parafilm 
and incubated at room temperature for 1 h. After 1 h blocking buffer was removed and 1 mL and 
500 µL of PBS were added to the basal and apical chambers, respectively. 
 
Figure 4.6. Schematic representations of immunofluorescence staining processes. All steps were 




            Antibody Staining. The PBS at the basal chambers was removed. All antibodies were 
prepared in the blocking buffer. First, 50 µL of primary antibodies was added to a piece of 
parafilm. The bottom of the Transwell® insert was wrapped by this parafilm to prevent antibody 
leaking from the apical to basal chambers. Then apical PBS was removed and 100 µL of primary 
antibodies was added to each apical chamber. The Transwell® plates were wrapped with parafilm 
and incubated at room temperature for 2 h or overnight at 4 °C. After 2 h or on the next day, the 
parafilm was removed from each Transwell® insert and the basal and apical chambers were wash 
with 1 mL and 500 µL of PBS, respectively. Transwell® inserts were washed with PBS 5 times 
on the rocking platform. For each wash, the old PBS was removed, fresh PBS was added to the 
basal and apical chambers and the Transwell® plates were set on the rocking platform for 4 min.  
 
For secondary antibody staining, 50 µL of secondary antibodies along with 1 μg/mL of 
DAPI was added to a piece of parafilm. Each Transwell® insert was wrapped by the parafilm at 
the bottom and placed back to the Transwell® plate. Then, 100 µL of secondary antibodies along 
with 1 μg/mL of DAPI was added to the apical chambers and the Transwell® plates were wrapped 
by parafilm and incubated at room temperature for 1 h. 
 
After 1 h the basal and apical chambers were wash with 1 mL and 500 µL of PBS, 
respectively. Transwell® inserts were washed with PBS 5 times on the rocking platform. For each 
wash, the old PBS was removed, fresh PBS was added to the basal and apical chambers and 




After the last wash, excess PBS was removed from the basal and apical sides of the porous 
Transwell® membrane and mounting media were added onto a slide. The Transwell® membrane 
was excised. This tissue section was sandwiched in between a cover slip and the slide and was 
cured at room temperature in the dark for 18-24 h prior to imaging.  
 
4.3.11 Characterization 
UV−vis−NIR spectra were measured with a Cary 5000 UV−vis−NIR spectrophotometer 
(Agilent Technologies, USA). Hydrodynamic diameters and zeta potential of AuNSs were 
determined by ZetaPALS Particle Size and Zeta Potential Analyzer (Brookhaven, USA). 
Transmission electron microscopy (TEM) of AuNSs was collected by a JEOL 2100 Cryo 
microscope (JEOL Ltd., Tokyo, Japan). Average core diameters of AuNSs were determined by 
ImageJ software (the National Institutes of Health, USA). At least 300 particles were counted to 
determine the sizes of AuNSs.  Epifluorescence imaging of SAEC was performed by a Zeiss 
Axiovert 200M microscope (ZEISS, Germany). 
 
4.4 Results and Discussion 
We built a 3D, human lung model to study how NP aerosols affect epithelial cell 
differentiation. Two AuNSs of different surface chemistry and charges were prepared. One was 
capped by negatively charged citrate and the other was wrapped by positively charged PAH. 
(Figure 4.7). Both AuNSs were of the same average sizes 44.4 ± 10.7 nm shown in Figure 4.8a, 
but with different surface coatings. To form positively charged PAH AuNSs, the surface chemistry 
of the as-synthesized citrate-capped AuNSs was modified by layer-by-layer polyelectrolyte 
coatings. The surface modification of AuNSs was confirmed by the shifts of localized surface 
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plasmon resonance (LSPR) peaks, the changes of interparticle potential from negative to positive, 
and increases in the hydrodynamic diameters (Figure 4.8c and Table 4.1). The LSPR peaks shifted 
from 531 to 533 nm after the citrate-capped AuNSs were wrapped by the second layer of PAH. 
The hydrodynamic diameters increased from 53.2 ± 0.3 to 58.2 ± 0.3 nm, and the interparticle 




Figure 4.7. A gold nanoparticle library of citrate-capped and triple-wrapped PAH NSs. 
 
All native AuNSs showed aggregation when directly added to the mixed cell culture 
medium composed of EGM-2 with 2% of FBS and PneumaCult™ ALI maintenance medium (1:1 
in volume). To improve particle stability, AuNSs were sequentially incubated with a mixture of 
proteins present in the mixed cell culture medium; then were suspended in the medium (Figure 
4.9a). We found that citrate-capped AuNSs of three different sizes were stable for three days when 
incubated with 1 v/v% of BSA-FAF and then 1 v/v% of FBS before mixed with the mixed media 
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(Figure 4.9b). Triple-wrapped PAH 44.4 nm AuNSs, however, were not stable in the mixed 
medium by this protocol.  
 
 
Figure 4.8. a) TEM image of citrate-capped AuNSs of average diameters 44.4 ± 10.7 (N=383). N 
refers to the number of particles measured. b) UV−vis−NIR spectra of AuNSs. The blue, green, 
black and red spectra correspond to citrate-, PAH- and PAA-capped and triple-wrapped PAH 
AuNSs, respectively. c) Changes of AuNS zeta potential after layer-by-layer polyelectrolyte 
coatings. Triple-wrapped PAH AuNSs were resulted from coating citrate-capped AuNSs (blue bar) 
with alternative, positively (PAH), negatively (PAA) and positively (PAH) charged 
polyelectrolytes. The green, black and red bars correspond to PAH- and PAA-capped and triple-





Figure 4.9. AuNS stability in the mixed media of EGM-2 with 2% FBS and PneumaCult™ ALI 
maintenance medium. a) Sequential protein incubation protocol. b) UV-vis-NIR spectra of all 
AuNSs. NSs were mixed with 1 v/v% of BSA-FAF, 1 v/v% of FBS and then the mixed media. 
The green, black, blue and red spectra correspond to citrate-capped AuNSs of 17.9 ± 3.2, 44.4 ± 
10.7 and 80.9 ± 9.8 nm, and triple-wrapped PAH AuNSs of 44.4 ± 10.7 nm in diameter, 
respectively. The spectra were taken after 1 h incubation with the mixed media.  
 
To make triple-wrapped PAH AuNSs of 44.4 nm stable in the mixed media. The v/v% of 
BSA-FAF and FBS was adjusted in the sequential incubation protocol. BSA-FAF was increased 
from 1 to 4 v/v% when FBS was fixed to 1 v/v%; the v/v% of BSA-FAF was fixed to 1, but FBS 
was decreased from 1 to 0.5 v/v%. Figure 10a shows the UV-vis-NIR spectra of triple-wrapped 
PAH AuNSs from 7 different incubation protocols. Sample 4 resulted from the sequential 
incubation protocol of 4 v/v% of BSA-FAF and 1 v/v% of FBS shows the narrowest LSPR peak 
with a slight shoulder on the right. To further investigate if increasing the v/v% of BSA-FAF will 
improve the stability of PAH coated NSs in the mixed media, BSA-FAF was increased from 5 to 
10 v/v% when FBS v/v% was still fixed to 1. The best result was triple-wrapped PAH AuNSs 
incubated with 10 v/v% of BSA-FAF and 5 v/v% of FBS. This incubation protocol makes triple-
106 
 
wrapped PAH AuNSs of 44.4 nm stable in the mixed media up to 3 days.  
 
Figure 4.10. Stability of AuNSs in the mixed media of EGM-2 with 2% FBS and PneumaCult™ 
ALI maintenance medium. a) UV-vis-NIR spectra of PAH AuNSs of 44.4 nm resulted from 7 
incubation protocols. Each protocol involved different v/v% of BSA-FAF and FBS. Sample 1 to 
4 were incubated with increasing BSA-FAF from 1-4 v/v%, respectively but with fixed 1 v/v% 
of FBS. Sample 5-7 were with fixed 1 v/v% of BSA-FAF, but with decreasing FBS from 1 to 2, 
0.8 and 0.5 v/v%, respectively. b) UV-vis-NIR spectra of citrate-capped and triple-wrapped PAH 
AuNSs of 44.4 nm in the mixed media. Both NSs were incubated with 10 v/v% of BSA-FAF and 
5 v/v% of FBS. The black and red spectra correspond to citrate-capped and triple-wrapped PAH 
NSs, respectively. c) UV-vis-NIR spectra of citrate-capped and triple-wrapped PAH AuNSs of 
44.4 nm in the mixed media. The black spectrum corresponds to citrate-capped NSs incubated 
with 1 v/v% of BSA-FAF and 1 v/v% of FBS. The red spectrum corresponds to triple-wrapped 
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Figure 4.10. (cont.) 
PAH NSs incubated with 10 v/v% of BSA-FAF and 5 v/v% of FBS. The spectra were taken on 
the third day of incubation.  
 
Although triple-wrapped PAH AuNSs were stable in the mixed media when incubated 
with 10 v/v% of BSA-FAF and 5 v/v% of FBS, citrate-capped AuNSs of the same size show 
aggregation (Figure 4.10b). All NSs are stable in this mixture of EGM-2 with 2% FBS and 
PneumaCult™ ALI maintenance medium, but citrate- and PAH-capped AuNSs require different 
protein incubation protocols. All citrate-capped AuNSs of three sizes are stable when incubated 
with 1 v/v% of BSA-FAF and 1 v/v% of FBS, but triple-wrapped PAH AuNSs of 44.4 nm require 
10 v/v% of BSA-FAF and 5 v/v% of FBS for stabilization (Figure 4.10c).  It is very interesting 
that additional BSA-FAF did not contribute to NP stabilization when AuNSs were citrate-capped. 
It has been shown that NPs of different surface chemistry and sizes adsorb different proteins, 
forming various protein corona.19-20 According to our data, it is possible that the composition of 
protein corona depends more on NP surface chemistry rather than sizes. Our preliminary results 
show that AuNSs of different surface chemistry requires different incubation protocols for NP 
stabilization; however, NP of the same surface chemistry, but with different sizes can be 
stabilized by the same protocol.  
 
Table 4.1 shows the hydrodynamic sizes and zeta potential of AuNSs in nanopure water 
and in the mixed media. After sequential protein incubation, the hydrodynamic sizes of AuNSs 
increase and all AuNSs show slightly negative zeta potential despite their initial surface charges. 
The average hydrodynamic sizes of citrate-capped and triple wrapped PAH NSs in nanopore water 
are 53.2 ± 0.3 and 58.2 ± 0.3 nm, respectively. After sequential protein incubation, the average 
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hydrodynamic sizes of citrate-capped and triple wrapped PAH AuNSs increase to 103.9 ± 0.8 and 
125.6 ± 0.5 nm, respectively. The interparticle potential of AuNSs also changes after protein 
incubation. When AuNSs were in nanopure water, citrate-capped NSs possessed negative surface 
charges (-20.6 ± 1.1 mV) and the triple-wrapped PAH NSs showed positive zeta potential (37.0 ± 
3.1 mV). After sequential protein incubation, similar surface charges were observed in both NSs ( 
-10.4 ± 0.6 and -7.6 ± 0.7 mV for citrate- and PAH-coated AuNSs, respectively) despite their 
distinct initial surface charges. The changes of NS hydrodynamic sizes and zeta potential from 
nanopure water to the mixed media may result from protein corona, which alters the surface 
chemistry of NPs after proteins adsorb to the NP surface.21-23 
 
Surface Nanopure water Mixed cell culture medium 












Citrate 531 53.2 ± 0.3 -20.6 ± 1.1 534 103.9 ± 0.8 -10.4 ± 0.6 
PAH 533 58.2 ± 0.3 37.0 ± 3.1 531 125.6 ± 0.5 -7.6 ± 0.7 
Table 4.1. Characterization of AuNSs in nanopure water and in the mixed cell culture medium 
(EGM-2 with 2% of FBS and PneumaCult™ ALI maintenance medium; 1:1 in volume). 
Hydrodynamic diameters were measured by dynamic light scattering (DLS). AuNSs were 
incubated with 1 v/v% of BSA-FAF and 1 v/v% of FBS for citrate-capped and 10 v/v% of BSA-
FAF and 5 v/v% of FBS for triple-wrapped PAH NSs and then mixed with the mixed medium. 
The hydrodynamic diameters of the mixed medium with additional 1 v/v% of BSA-FAF and 1 
v/v% of FBS and 10 v/v% of BSA-FAF and 5 v/v% of FBS were 20.5 ± 0.1 and 27.1 ± 0.3 nm, 
respectively. Zeta potential of the mixed medium with additional 1 v/v% of BSA-FAF and 1 v/v%  
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Table 4.1. (cont.) 
of FBS and 10 v/v% of BSA-FAF and 5 v/v% of FBS was -8.8 ± 0.5 and -7.7 ± 0.3 mV, 
respectively. All data were reported as mean ± standard deviation. 
 
To quantify the number of AuNSs delivered by the nebulizer, 6 different AuNS 
concentrations were prepared in the mixed media to establish a calibration curve. Figure 4.11-12 
show TEM images of aerosol delivery of ~50 nm AuNSs. The number of AuNSs deposited on a 
TEM grid decreases as the AuNS concentration in the nebulizer decreases. To estimate the 
number of AuNSs per cell, we counted the number of NSs in a fixed area. Then we used the 
number of NSs per area to calculate the number of NSs per cell based on our cell culture seeding 
density. For each concentration of AuNSs, 25 images were counted, and all images were 
randomly taken by 25x magnification with a fixed area of 847.3 x 847.3 nm2. We wanted to match 
our AuNS doses to the ambient and worst-case exposure as shown by Paur et al.18 The target 
tissue dose fluxes are 2 and 300 NPs/cell/h for the ambient and worst-case exposure, respectively. 
To deliver an eight-hour dose for 2 min nebulization, each cell should receive 16 and 2,400 NPs 
for the ambient and worst-case exposure, respectively. Below show the detailed calculations of 
the number of NSs per cell when 0.2 nM of AuNSs applied to the nebulizer. A Transwell® insert 
has a 6.5-mm diameter, which gives a surface area of 33 mm2. When the concentration of AuNSs 
in the nebulizer is 0.2 nM, total number of NSs on the apical Transwell® membrane is (2.1 × 10-
6 NSs/nm2) × (10-12 nm2/mm2) × 33 mm2 = 7.0 × 107 NSs. As 60,000 cells are seeded on the apical 
side of Transwell®, there are 7.0 × 107 NSs/60,000 cells = 1,170 NPs/cell. This linear relationship 
between the number of nebulized AuNSs deposited on a TEM grid and the NS concentration in 
the nebulizer is shown in Figure 4.12. Calibration curves for citrate-capped AuNSs of ~20 and 




Figure 4.11. Representative TEM images of nebulized, 50-nm AuNSs delivered from different 
NS concentrations in the nebulizer. a) to d) Deposition of citrate-capped AuNSs: a) 0.4, b) 0.2, c) 
0.1 and 0.07 nM of AuNSs in the nebulizer. e)-h) Deposition of triple-wrapped PAH AuNSs. a) 
0.5, b) 0.2, c) 0.1 and 0.07 nM of AuNSs in the nebulizer. All images were collected from 





Figure 4.12. a) Representative TEM image of nebulized, citrate-capped, 50-nm AuNSs from 0.07 
nM in the nebulizer.  b) to e) liner relationships between the number of nebulized AuNSs per cell 
and the AuNS concentration put in the nebulizer. Calibration curves of b) citrate-capped, 50-nm 
AuNSs with Y = 4883x + 25; R2 = 0.94851, c) triple-wrapped PAH, 50-nm AuNSs with Y = 5410x 
+ 51; R2 = 0.94553, d) citrate-capped, 20-nm AuNSs with Y = 3472x + 25; R2 = 0.95072 and e) 
citrate-capped, 80-nm AuNSs with Y = 8413x + 25; R2 = 0.94061. 
 
Our 3D lung model was exposed to two target tissue dose fluxes of AuNS Aerosols. One 
was realistic ambient exposure and the other was worst-case exposure, corresponding to 2 and 300 
NPs/cell/h, respectively.18 To deliver an 8-hour dose flux for 2 min nebulization, the AuNS 
concentrations of ambient and worst-case exposure to citrate-capped AuNSs were 0.0010 and 0.40 
nM, respectively.  Those for ambient and worst-case exposure to triple-wrapped PAH AuNSs were 
0.0035 nM and 0.43 nM, respectively. Two sets of experiments with slightly different conditions 
were done. For the first set of experiments, AuNS aerosols were performed on the 4th day after 
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SAEC was seeded on Transwell®. Since SAEC doubling time was 22 h, the number of cells on 
the apical chambers was estimated be quadrupled. However, the doubling time provided by the 
manufacture was calculated based on the monoculture of SAEC in a tissue culture flask, not on 
cocultures with a Transwell® insert. Therefore, the number of cells on Transwell® reported here 
was an estimation. We estimated our lung model received two dose fluxes: 2 and 300 NSs per cell 
for 8 h exposure. To accurately report tissue dose fluxes, we chose to report ambient and worst-
case exposure in terms of the number of NSs per area since the Transwell® insert has a fixed 
diameter. For ambient and worst-case exposure, there were 5.6 × 106 and 4.6 × 108 NSs/cm2, 
respectively. 
 
Figure 4.13-14 show that all 3D lung models possess a differentiated human small airway 
epithelium regardless of AuNS aerosol exposure. Controls with and without mixed medium 
aerosol exposure and the cocultures exposed to AuNS aerosols of both ambient and worst-case 
dose fluxes show an extensive, pseudostratified airway epithelium. Positive staining for 
differentiation markers confirmed full epithelium differentiation of goblet, ciliated, and club cells. 
All cocultures show extensive coverage of mucociliary differentiation. Figure 4.15-16 show a 
higher magnification of the differentiated human small airway epithelium with goblet, ciliated, 
and club cells labeled by MUC5AC (green), acetylated α-tubulin (orange), and uteroglobin (red), 
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To provide a better understanding of how AuNS aerosols affect our 3D lung model, we 
monitored the progression of inflammatory responses of the cocultures. We quantified changes of 
inflammatory responses present in the basil chambers after 8 h of NS aerosol exposure and on the 
3rd, 9th, 15th and 21st day after aerosol exposure. We chose three cytokines: TNF-α, TGF-β, and IL-
6.  TNF-α is a multifunctional cytokine, secreted by inflammatory and endothelial cells, and is 
involved in the regulation of cell proliferation, differentiation and apoptosis.24-25 TGF-β, abundant 
in lung tissue, regulates cell proliferation, differentiation, growth and inflammatory processes.26-27 
IL-6 responds to infections and tissue injuries and is primarily produced at sites of acute and 
chronic inflammation.28 Figure 4.17 show the progression of these three cytokines from the first 
day of NS aerosol exposure to the 21st day after exposure. Compared to the amounts of TGF-β and 
IL-6 released from our lung model, only minor changes of TNF-α were found throughout 21 days. 
The amounts of TNF-α fluctuate from 5-20 pg/mL. Cocultures exposed to all AuNS aerosols show 
decreases in TNF-α until the 9th day and the amount of TNF-α gradually increases toward the 21st 
day. On the 21st day, the highest amount of TNF-α occurs in the cocultures exposed to the worst-
case exposure of citrate-capped AuNSs. Unlike minor changes of TNF-α, the amount of TGF-β 
significantly increases on the 9th day and then gradually decreases toward the 21st day. Compared 
to the amounts of TGF-β on the 1st day, there are more than two-fold increases in TGF-β on the 9th 
day in all cocultures regardless of different aerosol exposure and doses. For example, TGF-β 
significantly increases from 535 ± 53 to 1685 ± 346 pg/mL in the cocultures received the worst-
case exposure to triple-wrapped PAH AuNSs. However, the amounts of TGF-β from all cocultures 
gradually decreases to approximate the initial amounts present on the first day, i.e., on the 21st day, 
TGF-β decreases to 681 ± 303 pg/mL in the cocultures received the worst-case exposure to triple-
wrapped PAH AuNSs. The minor changes of TNF-α throughout the 21 days and the recovery of 
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TGF-β on the 21st day explain that all cocultures, even though, exposed to different AuNS aerosols, 
could differentiate. The amounts of IL-6 from all cocultures, nevertheless, show a very different 
trend. Compared to the amounts of IL-6 present on the 1st day, there are more than three-fold 
increases in IL-6 on the 21st day in all cocultures exposed to AuNS aerosols regardless of different 
NS surface chemistry and doses. For example, IL-6 significantly increases from 593 ± 319 to 1846 
± 765 pg/mL in the cocultures received the ambient exposure to triple-wrapped PAH AuNSs. 
Although all human lung models successfully differentiated, continuous increases in IL-6 
throughout the 21 days show the possibility of chronic inflammation induced by AuNS aerosols 









Figure 4.17. Protein analyses of the cocultures exposed to one dose of citrate-capped and triple-
wrapped PAH AuNS aerosols. Mixed cell culture media in the basal chambers were collected after 
8 h of aerosol exposure and on the 3rd, 9th, 15th and 21st day after exposure. Changes of a) tumor 
necrosis factor (TNF-α), b) transforming growth factor beta (TGF-β), and c) interleukin 6 (IL-6). 
The black, red, blue and green spectra correspond to ambient and worst-case exposure to citrate-
capped AuNSs and ambient and worst-case exposure to triple-wrapped PAH NSs, respectively. 
 
A second set of experiments was conducted to better control the number of SAEC seeded 
on Transwell®. We exposed our 3D lung model to AuNS aerosols before SAEC reached 22 h 
doubling time. The airlift process was performed on the next day after SAEC was seeded and 
SAEC was immediately exposed to AuNS aerosols.  Although we exposed the cocultures to the 
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same the number of NSs per area, our lung model received different numbers of NSs per cell. 
There were 16 and 2400 NSs per cell for the ambient and worst-case exposure, respectively.  
 
Figure 4.18-19 show that all cocultures regardless of different aerosol exposure possess a 
differentiated, pseudostratified airway epithelium. Controls received mixed cell culture medium 
aerosols and cocultures exposed to AuNS aerosols show positive staining for goblet, ciliated, and 
club cells. All cocultures show an extensive coverage of mucociliary differentiation. Figure 4.20 
shows a higher magnification of the differentiated human small airway epithelium composed of 
goblet, ciliated, and club cells. There were no results for the cocultures exposed to the triple-
wrapped PAH NSs of the worst-case scenario because those Transwell® inserts showed signs of 
contamination 3 days before the 21st day. To avoid cross contamination, those inserts were 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































We constructed a NP library with AuNSs of the same core size, but with different surface 
coatings to investigate how AuNS surface chemistry and doses affected human airway epithelium 
differentiation. Two types of AuNSs, negatively charged, citrate-capped and positively charged, 
triple-wrapped PAH NSs, were delivered to the 3D cocultures of SAEC and HPAEC. To mimic 
human inhalation, we delivered AuNS aerosols to the lung model through an ultrasonic nebulizer. 
We also quantified the numbers of AuNS delivered by the nebulizer to match human realistic 
ambient and worst-case exposure for 8 h. Two sets of experiments with slightly different 
conditions were conducted. In both experiments, our human lung model received the same tissue 
dose fluxes with respect to the number of AuNSs/tissue area; however, with different numbers of 
AuNSs/cell. The tissue dose fluxes for ambient and worst-case exposure were 5.6 × 106 and 4.6 × 
108 NSs/cm2, respectively. The ambient and worst-case exposure were 2 and 300 NSs per cell for 
the first experiment; 16 and 2400 NSs per cell for the second experiment, respectively. In both 
experiments, all human lung cocultures exposed to ambient and worst-case exposure show 
successful epithelium differentiation of goblet, ciliated and club cells. To shed light on how the 
3D cocultures responded to AuNS aerosols, we monitored the changes of 3 cytokines (TNF-α, 
TGF-β and IL-6) present in the cocultures. All cytokines show different progression patterns from 
the first day of AuNS aerosol exposure to the end of 21st day. Although all human lung models 
successfully differentiated, we observe continuous increases in IL-6 throughout the 21 days, 
indicating the possibility of chronic inflammation induced by AuNS aerosols regardless of NS 





4.6 Future Work 
We planned to repeat the experiment to confirm the impact of AuNS aerosols on human 
lung epithelium differentiation. To provide valuable insight into the physiological responses of the 
3D lung model after aerosol exposure, we would like to study more protein in additional to TNF-
α, TGF-β and IL-6. They are interleukin 8 (IL-8), vascular endothelial growth factor A (VEGFA), 
and uteroglobin (UGB). IL8, a chemokine produced by macrophages, epithelial and endothelial 
cells, is a major mediator of the inflammatory response and has been shown to play a role in the 
pathogenesis of bronchiolitis.29-30 VEGFA is a growth factor inducing proliferation and migration 
of vascular endothelial cells and is essential for both physiological and pathological 
angiogenesis.31 UGB is a protein expressed in mucus-secreting cells present in the bronchial 
epithelium. The secreted mucus is important for maintaining a suitable environment for ciliary 
function and protection against airborne infectious agents and particles.5 This protein has been 
implicated in anti-inflammatory and epithelial regeneration after oxidant-induced injury.32 Defects 
in this protein are associated with asthma.33 
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CHAPTER 5: CONCLUSIONS AND OUTLOOK 
 
5.1 Conclusions and Outlook 
We have shown how to tune the longitudinal localized surface plasmon resonance (LSPR) 
of gold nanorods (AuNRs) beyond 1000 nm, but precisely control the widths of AuNRs less than 
10 nm by seed-mediated growth. Two reducing agents, ascorbic acid and hydroquinone, were used 
to synthesize mini AuNRs of 9 different aspect ratios (AR 2.2 to 10.8), resulting in longitudinal 
LSPR from ~600 to > 1300 nm. We modified the concentrations of silver nitrate, seed, and 
hydrochloric acid in the growth solutions to finely tune the lengths of mini AuNRs from 19 to 93 
nm but accompanied by average widths all below 10 nm. Our mini AuNR syntheses result in an 
average shape yield of 96% in rods, and > 79% yields compared to initial gold ion concentrations. 
We also demonstrate the dimensions, ARs and shape percent yields from small-and large-scale 
syntheses of mini AuNRs are comparable. We have achieved synthesizing AuNRs of smaller 
dimensions but still maintaining tunable plasmonic properties, which opens the possibilities for 
better photothermal therapy efficiency,1 higher cellular uptake, greater tumor accumulation, faster 
organ clearance and lower in vitro and in vivo toxicity.2-3 
 
Not only the optical properties of gold nanoparticles (AuNPs) are size-dependent, we have 
shown that AuNR sizes also influence NP cellular uptake. To correlate how each size parameter 
(width, length, AR and volume) affects the endo-and exocytosis of AuNRs, AuNRs of four distinct 
dimensions along with three ARs (2.6, 5.2 and 9.7) were prepared and were functionalized with 
methoxy poly(ethylene glycol) thiol. We found that AuNRs of the same AR, but with different 
dimensions show different endocytosed amounts by primary human pulmonary artery endothelial 
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cells (HPAEC). Regardless of the same AR, AuNRs of the smaller dimensions were endocytosed 
twofold more than those of larger dimensions. Low correlations exist between the endocytosis of 
AuNRs and rod volumes, lengths and ARs (R2 < 0.18). We, however, found a negative correlation 
(R2 = 0.6501) between HPAEC uptake of AuNRs and rod widths. AuNRs with average widths less 
than 10 nm were endocytosed more by HPAEC than those with average widths larger than 10 nm 
despite ARs. This shows that the cellular uptake of AuNRs depends more on the widths rather than 
the lengths, ARs and volumes of rods. We also investigated AuNR exocytoses in a 10 h interval. 
Our result shows that at the end of 10 h, > 75% of rods were removed from HPAEC regardless of 
AuNR sizes. Upcoming experiments related to size-dependent endo-and exocytosis of AuNRs 
would explore the differences of cellular uptake and removal of AuNRs between different cell types 
of the same organ, i.e., human pulmonary endothelial and epithelial cells and fibroblasts. Kinnear 
et al. observed polyvinylpyrrolidone-coated AuNRs with an AR larger than 5 were preferentially 
endocytosed by human lung epithelial carcinoma cells (A549) compared to J774A.1 
macrophages.4 However, for AuNRs with ARs less than 5, there exists no size-dependent 
endocytosis of AuNRs. A thorough understanding of how NP sizes influence  endo-and exocytosis 
could improve the sensitivity of imaging and diagnostic, and the efficiency of drug release and 
photothermal therapy.  
 
To better understand the health implications of inhaled NP aerosols, we mimicked the 
composition and physiological function of human lungs by engineering a 3-dimentional lung 
model cultured at an air-liquid interface. We investigated the impact of gold nanosphere (AuNS) 
aerosols on human small airway epithelium differentiation at a pulmonary blood-air barrier. Gold 
nanospheres of different surface chemistry were prepared, including negatively charged, citrate-
capped and positively charged, triple-wrapped poly(allylamine hydrochloride) (PAH) NSs. AuNS 
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aerosols were delivered to the cocultures of primary human small airway epithelial and pulmonary 
artery endothelial cells through nebulization to mimic human inhalation. We exposed our lung 
models to human realistic ambient and worst-case exposure with tissue dose fluxes 5.6 × 106 and 
4.6 × 108 NSs/cm2, respectively. All human lung models exposed to AuNS aerosols, including the 
ambient and worst-case exposure to citrate-capped and triple-wrapped PAH AuNSs, successfully 
differentiated into goblet, ciliated and club cells. To investigate the impact of AuNS aerosols at 
the molecular level, we report three cytokine changes from the 1st day of AuNS aerosol exposure 
to the end of the 21st day until epithelia differentiated. We found minor changes in TNF-α 
throughout 21 days. Significant increases in TGF-β, however, were observed on the 9th day, but 
gradual decreases toward the 21st day. We observed three-fold increases of IL-6 occurred in the 
cocultures exposed to all AuNS aerosols despite NP surface chemistry and doses, indicating 
chronic inflammation produced at the sites although all human lung models successfully 
differentiated.  
 
We aim to develop a lung-on-a-chip with mechanical stretch and fluid flow to better mimic 
a pulmonary microenvironment. We plan to monitor short- and long-term morphological and 
molecular changes of the pulmonary microenvironment in the presence and absence of AuNP 
aerosols by real-time fluorescence images5 and protein and metabolite analyses.6 Upcoming 
experiments toward this aim include 1) fabrication of a lung-on-a-chip model with mechanical 
stimuli,7-8 2) verification of on-chip mucin secretion and longevity of human lung triple cell 
cocultures, 3) live-cell imaging of blood-air barrier integrity,9 actin remodeling,10 intracellular 
junction dynamic and paracellular transport11 and 4) NP aerosol delivery and short- and long-term 
assessment of the lung microenvironment. A multichannel microfluidic device will be built to 
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mimic a 3-dimensional lung. Two channels will be separated by a porous membrane, allowing for 
transcellular transport between lung epithelial and endothelial cells. To mimic the physiological 
complexity of a lung, three types of cells will be used including human lung epithelial and 
endothelial cells and macrophages. We will confirm the lung composition and cell viability by 
immunofluorescence staining and test on-chip lung function via measuring lung specific 
metabolites. Then, AuNP aerosols will be introduced to our lung-on-a-chip model. The lung 
microenvironment will be monitored constantly to elucidate the differences of metabolites, mucin 
secretion and inflammatory responses between the lung models with and without AuNP aerosol 
exposure. Finally, we seek to compare functional, morphological and molecular changes on 
stretchable lung-on-a-chip and static coculture models in response to AuNP aerosols by 
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